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Serious mental illnesses (SMIs) often have an onset early in life and go on to produce disability 
and functional impairment, which require ongoing supportive services and loss of productivity. 
Bipolar disorder (BD) and schizophrenia (SZ) are two of the most common SMIs. BD and SZ 
differ in their pattern of neurocognitive performance, which suggests differences in the severity 
of functional impairment between the illness groups. Within these psychiatric illness groups, 
subgroups may also be identified using cluster analysis. Evidence points to heterogeneity in 
functional outcomes in BD and SZ, yet very little research has assessed for subgroups based on 
functional capacity within these psychiatric groups. To examine this manner, the current study 
utilized archival data from ongoing research studies conducted in the Neuropsychology Research 
Program (NRP) laboratory at the University of Nevada, Las Vegas (UNLV). The sample 
consisted of 250 adults with a primary diagnosis of BD (n = 129) or SZ (n = 71) and healthy 
controls (HC; n = 50). The primary measure of functional capacity was a performance-based task 
called the University of California, San Diego (UCSD) Performance-Based Skills Assessment 
(UPSA; Patterson et al., 2001). Distinct functional capacity profiles in BD and SZ were 
identified using cluster analysis. Results demonstrated that clusters were differentiated primarily 
by pattern of performance in the clinical groups and there were differences between the 
psychiatric groups in the number of clusters identified. A three-cluster solution was optimal for 
BD, whereas a five-cluster solution best captured heterogeneity in SZ. Normal functioning 
clusters were identified in both clinical groups. The SZ group demonstrated greater overall 
impairment compared to BD and healthy controls. For adults with BD or SZ, cluster membership 
was associated with differences on a number of outcome variables, supporting the external 
validity of the cluster solutions. The current findings provide support for the idea that there is 
	
 	iv 
substantial heterogeneity in functional abilities for individuals with SMIs with differential impact 
on functional capacity. Identifying subgroups based on functional capacity may have 
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Chapter 1: Introduction to Bipolar Disorder and Schizophrenia 
 Serious mental illnesses (SMIs) are associated with significant societal costs. These costs 
rival common prevalent medical conditions, such as cancer, heart disease, stroke, and diabetes 
(National Center for Chronic Disease Prevention and Health Promotion, 2018). SMIs often have 
an onset early in life and go on to produce disability and functional impairment, which require 
ongoing supportive services and loss of productivity (Cloutier et al., 2016; Cloutier, Greene, 
Guerin, Touya, & Wu, 2018). There is some decrease in life expectancy associated with these 
disorders, although most affected individuals will have a normal life expectancy and require the 
need for ongoing treatment during that time period. Bipolar disorder (BD) and schizophrenia 
(SZ) are two of the most common SMIs (American Psychiatric Association [APA], 2013).  
 BD is an affective disorder that affects approximately 1.8-2.8% of individuals worldwide 
(APA, 2013; National Institute of Mental Health [NIMH], 2017). The illness is characterized by 
alternating episodes of mania or hypomanic, depression, and normal mood. BD is associated 
with significant functional impairment and mortality, with as many as 36% of individuals with 
BD attempting suicide at least once and between 4% and 19% dying from suicide (Novick, 
Swartz, & Frank, 2010).  
 In addition, instability often associated with BD may complicate existing medical 
conditions or put individuals at risk for developing health conditions in the future (McElroy et 
al., 2002). Individuals with BD possess several risk factors for medical conditions, like lower 
socioeconomic status (SES), lack of access to health care, difficulty adhering to medical 
regimens, tobacco use, substance abuse, binge eating, and an inactive lifestyle. In addition, 
medications used to treat symptoms of BD are associated with negative effects on physical 
health. This includes lithium, an effective and commonly prescribed medication for BD that is 
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associated with an increased risk of hypothyroidism (Lambert et al., 2016). Research with 
individuals with BD has also demonstrated neurocognitive impairments when these individuals 
are compared to healthy controls (Forcada et al., 2015), and these deficits may fluctuate 
depending on mood state. Costs associated with BD are estimated to be up to $202.1 billion per 
year (depending on diagnostic subtype). This includes costs associated with treatment but also up 
to $113.18 billion associated with disability and functional impairment (Cloutier et al., 2018). 
 SZ is another psychiatric disorder that is associated with cognitive and functional 
impairments (MacDonald & Schulz, 2009), affecting approximately 0.3-0.7% of individuals 
worldwide (APA, 2013). The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition 
(DSM-5; APA, 2013) considers SZ a psychotic disorder, characterized by the presence of 
hallucinations and/or delusions. Common symptoms of SZ include disorganized speech, 
disorganized or catatonic behavior, and negative symptoms such as flat affect and the lack of 
motivation to initiate and perform purposeful activities. SZ symptoms can be categorized into 
positive and negative symptoms. Positive symptoms include abnormal experiences like 
hallucinations or delusions. In contrast, negative symptoms represent a category of symptoms 
indicative of the absence of “normal” behavior, including the paucity of thoughts, a decrease in 
emotional expression, and lack of motivation. Symptoms such as inappropriate social 
interactions, unusual behavior, social withdrawal, and low engagement self-care activities are 
also common in SZ (APA, 2013).  
 Individuals with SZ may also have difficulty with recognizing or addressing co-occurring 
chronic medical conditions (Olfson, Gerhard, Huang, Crystal, & Stroup, 2015). The negative 
effects of poor adherence to medication regimens exacerbate the symptoms of health conditions, 
and in turn, are associated with a premature mortality rate in SZ (Velligan et al., 2009). Some 
 
  3 
antipsychotic medications commonly prescribed for SZ are also associated with an increased risk 
for myocarditis, cardiomyopathy, cardiovascular disease, and sudden cardiac death (Raedler, 
2010). It is also important to note that the lifetime risk for suicide is 5% in SZ, with the highest 
risk in the early stages of illness (Hor & Taylor, 2010; Palmer, Pankratz, & Bostwick, 2005). 
Like BD, SZ also results in significant functional impairment and associated costs for treatment, 
ongoing supportive services, and lost productivity. Costs associated with SZ are estimated to be 
$155.7 billion per year. This includes direct healthcare costs but also up to $112.1 billion is 
associated with disability and functional impairment (Cloutier et al., 2016). 
 Although BD and SZ are typically diagnosed clinically using the DSM-5, recent 
advances in neuropsychology have identified key neurocognitive differences between individuals 
with and without the disorders. Though these differences alone cannot be used to diagnose BD 
and SZ, they have provided valuable information regarding etiologic and predisposing factors, 
severity, subtype, pathology, and functional outcomes of patients. Functional outcomes tend to 
be poorer for individuals with these conditions, as compared to healthy controls, largely due to 
neurocognitive deficits that limit functional capacity.  
 Functional deficits are especially evident in interpersonal, occupational, and academic 
domains (Cardenas et al., 2008; Bonnín et al., 2010; Harvey, Velligan, & Bellack, 2007; 
Mausbach et al., 2010; Mausbach, Tiznado, Cardenas, Jeste, & Patterson, 2016). The conditions 
are also associated with difficulties carrying out daily living skills, such as household chores, 
managing finances, and medication management (Mausbach et al., 2010). Research has generally 
demonstrated that SZ is associated with more severe functional impairment compared to BD. 
There is also substantial heterogeneity in functional impairment in BD and SZ. Within both 




normal functioning. The extent to which impairments in specific functional domains (e.g., 
finances, medication management, communication skills) has not been examined in the BD or 
SZ literature, although variability in functional impairment within and between individuals may 
have important implications for outcomes. 
 The current paper will examine this matter using cluster analysis to investigate functional 
heterogeneity in BD and SZ.  The psychiatric groups differ in their pattern of neurocognitive 
performance, which suggests differences in the severity of functional impairment between the 
groups (Mausbach et al., 2010). Within these illness groups, subgroups may also be identified 
using cluster analysis. Although evidence points to heterogeneity in functional outcomes in BD 
and SZ, very little research has assessed for subgroups based on functional capacity within these 
psychiatric groups. Therefore, a goal of the current study is to fill this gap in the literature by 
utilizing a cluster analytic approach. Identifying subgroups based on functional capacity may 





Chapter 2: A Literature Review 
Bipolar Disorder: An Overview 
 BD is one of the oldest recorded psychiatric illnesses in the field of mental health 
(Marneros & Angst, 2000). The disorder has its roots in the classical period, during which Greek 
physicians identified the distinct conditions of mania and melancholia. Hippocrates was the first 
physician to describe melancholia and mania in scientific terms through observations and 
longitudinal studies. He defined melancholia as pervasive experiences of anxiety and moodiness. 
Emil Kraepelin, an influential figure in founding modern psychiatry, dichotomized psychotic 
states into dementia praecox and manic-depressive insanity (Marneros & Angst, 2000). 
Kraepelin included all forms of mood disorders in the manic-depressive insanity state, including 
unipolar depression. His work was influential in building up the field of psychiatry and the 
concept of mental illness. Kraepelin faced opposition from other medical professionals of his 
time, who believed that manic-depressive insanity was too simplistic. Among them was Carl 
Wernicke, who strongly argued for different subtypes of melancholia, including types that may 
be recognized today as forms of unipolar depression (Marneros & Angst, 2000). Later, 
physicians such as Karl Kleist and Karl Leonhard differentiated between unipolar and bipolar 
disorders. Though they put forth various subtypes and classifications that are not used in the 
study of BD today, Wernicke, Kleist, and Leonhard must be credited as being the first physicians 
to separate and label unipolar and bipolar disorder.  
 In the United States (US), the DSM-I and DSM-II (APA, 1952, 1968) heavily reflected 
American psychologist Adolf Meyer’s views on mental illness, which was predominantly 
psychodynamic in nature and made little effort to deviate from Kraepelin’s “manic-depressive” 




categorically defined, symptom-based system (Mayes & Horwitz, 2005). As BD gained 
mainstream approval, researchers identified subtypes of the disorder. Bipolar II (BD II), which is 
characterized by hypomania (APA, 2013), has gained recent attention in the last few decades. 
Schizoaffective disorder has also gained prominence as a disorder that should be separated from 
affective disorders and distinct from schizophrenia (APA, 2013). The body of research on mixed 
states, cyclothymia, and substance-induced subtypes has also grown.  
Diagnostic Criteria for Bipolar Disorder 
 BD is diagnosed using the DSM-5’s diagnostic criteria (APA, 2013). There are 2 types of 
BD: BD I and BD II. Both types are characterized by episodes of extreme highs and extreme 
lows. The highs are known as manic or hypomanic episodes, whereas the lows are depressive 
episodes. A main difference between BD I and BD II lies in the severity of the manic episodes 
caused by each type. In BD II, the manic episode is less severe than what is exhibited in BD I, 
and is termed hypomania. Behaviors exhibited within a hypomanic episode may be considered 
atypical behavior for an individual, but not necessarily “abnormal” based on societal norms. In 
contrast, manic behaviors are more extreme and are typically considered abnormal. The “lows” 
(i.e., depressive episodes) experienced in BD I and BD II tend to be similar.  
 A manic episode is characterized by a period of at least one week during which the 
person is in an abnormally and persistently elevated or irritable mood (APA, 2013). A euphoric 
mood is the classical expectation of the manic episode; however, the person may instead be 
predominately irritable. A patient may also alternate back and forth between the mood states. 
This period of mania must be marked by three of the following symptoms to a significant degree 
(if the person is only irritable, they must experience four of the following symptoms): inflated 




difficult to interrupt or angry tirades), racing thoughts, distractibility, increase in goal-directed 
activity or psychomotor agitation (e.g., inability to sit still or pacing around), and excessive 
involvement in pleasurable activities that have a high risk consequence. As mentioned above, a 
hypomanic episode is very similar to a manic one, but less intense. It is only required to persist 
for 4 days and it should be observable by others that the person is noticeably different from their 
regular, non-depressed mood. A hypomanic episode is not severe enough to cause marked 
impairment in social or occupational functioning or to necessitate hospitalization (APA, 2013). 
Neurocognition in Bipolar Disorder 
 Neurocognition refers to cognitive processes linked to regions and networks in the brain 
such as executive functioning, memory, processing speed, attention, and perception (Burdick & 
Goldberg, 2008). Common neurocognitive deficits found in BD exist in the domains of attention, 
executive functioning, and memory (Clark & Goodwin, 2008; Mann-Wrobel, Carreno, & 
Dickinson, 2011). Deficits in attention and executive functions may be linked to 
pathophysiological mechanisms found in the prefrontal cortex and anterior cingulate cortex, 
which have been implicated as impaired in BD (Strakowski et al., 2000). In addition, pathology 
in basal ganglia has been linked to BD (Strakowski et al., 2000), and such pathology may impair 
the connectivity between the frontal cortex and basal ganglia, further impeding attention and 
executive functions.  
 Theories regarding the etiology of neurocognitive deficits in BD have been proposed, yet 
additional research is warranted to better understand these factors. Existing research suggests 
that a severe course of illness is associated with greater neurocognitive impairment and 
functional disability. Studies have found a negative association between the number of episodes, 




al., 2012). It should be noted that neurocognitive deficits are present at the onset of the illness, as 
well as shortly after the resolution of a first manic episode (Torres et al., 2010). Researchers have 
proposed that recurring episodes of the illness may lead to increasing damage to brain tissue, and 
subsequently, impact neurocognitive skills (Altshuler, 1993). These findings have led to the 
hypothesis that BD follows a progressive disease pattern (Cardoso, Bauer, Meyer, Kapczinski, & 
Soares, 2015; Chowdhury, Ferrier, & Thompson, 2003).  
 Given that BD may be a progressive disease, it is important to identify and understand the 
factors that may protect against neurocognitive impairments and promote functional 
independence. Higher baseline intellectual ability has been shown to be associated with 
increased stability in neurocognition over time for individuals with BD (Hinrichs et al., 2017). 
Lower verbal IQ scores and fewer years of education are associated with increased cognitive 
decline. Therefore, researchers have hypothesized that higher intellectual ability may buffer 
against neurocognitive decline for individuals with BD (Hinrichs et al., 2017). Forcada and 
colleagues (2015) examined the concept of cognitive reserve (CR) in BD and control 
participants. Three methods were used to assess for CR: 1) educational and work attainment, 2) 
involvement in leisure, cognitively stimulating, physical and social activities, and 3) the 
Vocabulary subtest of the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III; Wechsler, 
1997). Cognitive reserve was significantly associated with psychosocial functioning, as 
measured by the Functioning Assessment Short Test (FAST; Rosa et al., 2007) in BD patients. 
BD participants had worse neurocognitive performance and psychosocial functioning when 
compared to healthy controls. The authors suggest that the concept of CR may be important 





State vs. Trait Related Deficits  
 Another important consideration is whether neurocognitive dysfunctions are state or trait-
related. State-related deficits are characterized as transient and may change across mood 
episodes, while trait-related deficits are enduring and may reflect either underlying genetic 
components or acquired deficits that reflect length or severity of illness. Studies of unaffected 
first-degree relative of individuals with BD identify a pattern of neurocognitive deficits 
consistent with those observed in individuals affected by the disorder. These findings support the 
presence of trait-related deficits in BD and suggest these deficits are core features of the disorder 
(Frantom, Allen, & Cross, 2008; Georgiades et al., 2016).  
Regarding state deficits, several studies have addressed this consideration by studying 
specific mood states of BD (euthymic, depressed, and manic). Growing evidence suggests that 
individuals with BD experience neurocognitive impairment not only during depressive and 
manic episodes, but also during stable mood states (Bearden et al., 2011; Gruber, Rathgeber, 
Braunig, & Gauggel, 2007; Malhi et al., 2007; Mann-Wrobel et al., 2011). A meta-analysis 
demonstrated that individuals in the euthymic stage of the illness demonstrated impaired 
functioning across several neurocognitive domains (i.e., processing speed, executive functions, 
verbal memory and episodic and working memory) as opposed to control participants (Mann-
Wrobel et al., 2011). However, neurocognitive impairments are more prevalent during acute 
manic phases of BD than in depressed or euthymic states (Kurtz & Gerraty, 2009). A previous 
study examining neurocognitive functioning among all BD groups (euthymic, depressed, and 
manic) found that all groups were impaired when compared to control participants on several 
skills of executive functioning (i.e., inhibitory control, response initiation, and strategic 




Kravariti, Frith, Murray, & McGuire, 2004). As demonstrated by the findings of the 
aforementioned studies, it is evident that neurocognitive impairments can be found in all three 
states of BD. Symptom severity may fluctuate depending on the state; however, neurocognitive 
impairment is still present in the euthymic mood state. This implies that neurocognitive 
impairment is a core feature of BD and independent of mood state. Research has demonstrated 
that neurocognitive deficits in all mood states of BD are negatively associated with greater 
functional disability, such as difficulties related to independent living (Henry, Minassian, & 
Perry, 2013; Wingo, Harvey, and Baldessarini, 2009).  
Functional Capacity in Bipolar Disorder  
 In the early study of BD, prognosis for the illness was considered relatively promising, in 
part due to the assumption that neurocognitive deficits were not a core feature of BD. Just as 
more recent findings have clearly documented neurocognitive deficits in BD, recent studies also 
suggest poor functional outcomes for individuals living with the disorder. Significant disability is 
present during manic or depressed episodes, which has been apparent since the diagnosis was 
first suggested. Consequently, this type of disability is a diagnostic criterion used to identify 
these mood episodes. However, in the early research on BD, little evidence pointed to functional 
impairments during the euthymic state of the disorder, with some even suggesting that an 
individual may return to full functioning following a mood episode (Rennie, 1942). More recent 
research findings (e.g., Bearden et al., 2011; Strejilevich et al., 2013; Wingo, Baldessarini, 
Holtzheimer, & Harvey, 2010; Wingo et al., 2009) have challenged the notion that only some 
patients with BD achieve complete syndromal and functional recovery between episodes, with 
many individuals never returning to premorbid functioning levels after major affective symptoms 




that there will be residual impairment for most, which is apparent when individuals with BD are 
compared to their own baseline level of functioning, as well as the functioning of their first-
degree relatives without BD and control participants (Zarate, Tohen, Land, & Cavanagh, 2000). 
Other individuals will demonstrate little inter-episode recovery with ongoing and severe 
functional impairment even in the absence of an active mood episode (Wingo et al., 2010). These 
impairments may have an impact on self-care as well as educational, occupational, and 
interpersonal domains. Wingo and colleagues (2010) found that higher education level, being 
married, and fewer years living with BD significantly predicted better functional recovery 
(defined as returning to premorbid residential and vocational status) after controlling for residual 
depressive symptoms, BD subtype (I or II), and comorbid psychiatric illnesses.  
 Furthermore, a small number of studies have examined the relationships between clinical 
variables, neurocognition, and functional outcomes in BD. Allen, Bello, and Thaler (2015) found 
that verbal memory and learning deficits were predictive of poor functional capacity in euthymic 
BD. Bearden and colleagues (2011) found that neurocognitive impairments in episodic memory, 
visual scanning, working memory/attention, and processing speed each independently predicted 
concurrent occupational impairment in euthymic patients. In a longitudinal study following 
patients with BD for 4 years, Bonnín and colleagues (2010) found deficits in delayed verbal 
memory and depressive symptomology to be predictive of psychosocial functioning in BD, 
measured by total scores on the FAST (Rosa et al., 2007). The study also found that executive 
functioning deficits and depressive symptoms were predictive of poor occupational functioning 
(measured by the occupational subscale score on the FAST; Rosa et al., 2007). In another study 
examining functional outcomes in euthymic patients, deficits in executive functioning and 




scores  (Marino et al., 2010). The findings of the studies mentioned above demonstrate the 
influential impact of neurocognitive functioning on functional capacity in BD.  
Schizophrenia: An Overview 
 Like BD, SZ is one of the oldest recorded psychiatric illnesses (Kyziridis, 2005). In 1887, 
Emil Kraepelin first identified SZ as a discrete mental illness, which he termed dementia praecox 
(i.e., early dementia). Kraepelin’s work was primarily conducted with younger adults, with a 
goal of differentiating dementia praecox from other forms of dementia that usually occur later in 
life (e.g., Alzheimer’s disease). Among patients with the illness, he discovered symptoms such as 
uncontrollable laughing or crying without reason and emotional dullness. Kraepelin noted that 
the course of illness generally worsened with time. In 1919, Eugen Bleuler was the first to call 
the illness schizophrenia. The word schizophrenia comes from the Greek roots schizo (split) and 
phrene (mind) to describe the thinking of people with the disorder. The term was not meant to 
imply split mind or multiple personality, which is now termed dissociative identity disorder 
(APA, 2013).  
 Kraepelin and Bleuler both divided SZ into categories based on symptomology and 
prognosis. In previous versions of the DSM, five categories were used: disorganized, catatonic, 
paranoid, residual, and undifferentiated (with the first three categories proposed in Kraepelin’s 
work). The DSM-5 eliminated these subcategories because they have failed to demonstrate 
significant clinical utility, validity, or reliability (Kyziridis, 2005). In research and clinical 
settings, other techniques can be used to classify types of the disorder, including differentiating 
between positive and negative symptoms, examining severity and progression of symptoms over 
time, and identifying co-morbid psychiatric conditions. The previously mentioned methods may 




 Diagnostic Criteria for Schizophrenia 
To be diagnosed with SZ, an individual must consistently exhibit two or more of 
following symptoms for at least one month (Criterion A): 1) hallucinations, 2) delusions, 3) 
disorganized speech (which may be manifested as incoherent speech or losing track of one’s 
thoughts), 4) catatonic or disorganized movement, and negative symptoms (e.g., lack of 
emotional expression) (APA, 2013). The symptoms must lead to impairment in at least one of 
three major functional domains: self-care, occupational, or interpersonal functioning (Criterion 
B). Some signs of the disorder have been present for at least 6 months (Criterion C), and must 
include at least one month of symptoms that meet criterion A (active phase symptoms) in 
addition to prodromal or residual symptoms. BD, unipolar depression, and schizoaffective 
disorder (Criterion D), as well as issues related substance use or abuse (Criterion E) should also 
be ruled out for a diagnosis of SZ. The aforementioned disorders and symptoms may overlap 
with SZ symptomology, and may make differential diagnosis challenging for researchers and 
clinicians.  
Neurocognition in Schizophrenia 
 SZ is commonly thought of as an illness associated with hearing voices, seeing visions, 
and/or delusional thoughts. Research has demonstrated that hallucinations and delusions within 
SZ are debilitating symptoms that impact everyday functioning. However, neurocognitive 
impairment is one of the most influential predictors of functioning and quality of life in SZ 
(Nuechterlein et al., 2011). Research has shown that neurocognitive impairment is typically 
present prior to a formal diagnosis of SZ, with additional decline occurring after the first 
psychotic episode (Sponheim et al., 2010). Individuals with SZ tend to demonstrate a globalized 




sensory processing, episodic and working memory, and language and executive functions 
(Lepage, Bodnar, & Bowie, 2014; Mesholam-Gately, Giuliano, Goff, Faraone, & Seidman, 
2009). It is theorized that impairment in the functioning of the dorsolateral prefrontal cortex 
(DLPFC) impacts interactions with other brain regions (the striatum, thalamus, and parietal 
cortex) and neurotransmitter systems (glutamate, GABA, and dopamine) in SZ. This in turn 
impacts one’s ability to initiate and execute goal directed behaviors (Barch & Ceaser, 2012).  
Some studies have noted differences in neurocognition between BD and SZ. SZ is 
generally associated with more generalized cognitive deficits, whereas BD tends to be more 
selective in terms of its pattern of impairment. In BD, the most consistent impairments are in 
attention, verbal learning, and executive functioning skills (Arts, Jabben, Krabbendamm, & van 
Os, 2008; Robinson & Ferrier, 2006). Premorbid and current IQs tend to be higher in individuals 
with BD, as compared to those with SZ (Vöhringer et al., 2013). Neurocognitive deficits impact 
the ability to be adherent to medical and psychological treatment, initiate and engage in 
appropriate behaviors, and learn and implement skills needed to successfully navigate in the real 
world. Deficits in this domain place an upper limit on one’s ability to carry out functional 
behaviors. Similar to BD, neurocognitive deficits in SZ have been linked to more functional 
disability (Bowie et al., 2010; Mausbach et al., 2008).  
Functional Capacity in Schizophrenia  
 Functional capacity in SZ is important to study, given that approximately two-thirds of 
patients with SZ are unable to carry out the responsibilities of social roles like parent, spouse, 
student, and employee. (Harvey et al., 2007). Furthermore, the majority of individuals with SZ 




board-and-care home or skilled nursing facility (Mausbach et al., 2008) or experience 
homelessness (The World Health Organization, 2012). 
 Additionally, a core symptom of SZ is impairment in social interactions. Individuals with 
SZ tend to be socially isolated and have difficulty initiating and engaging in appropriate 
conversations. They may be unable to express their needs and feelings to others or develop 
meaningful relationships. Compared to control participants, individuals with SZ have smaller 
social networks and report lower levels of social support (Horan, Subotnik, Snyder, & 
Nuechterlein, 2006). The functional impairments observed in SZ tend to be more severe than 
what is observed in BD (Bowie et al., 2010). In addition, these impairments are present even 
when psychotic symptoms are in remission (Harvey et al., 2007).  
Psychotic Features in Bipolar Disorder 
 Patients with BD may express psychotic symptoms during manic episodes, blurring the 
line between affective and psychotic disorders. Molecular and epidemiological studies suggest 
overlap between affective and psychosis disorders (Pearlson, 2015), supporting a link between 
the two disorders. Furthermore, it may be challenging to distinguish between schizoaffective 
disorder and BD with psychotic features (BD+). BD and SZ may represent two ends of a 
spectrum of disease with shared underlying genetic and cognitive traits, with BD on the affective 
side and SZ on the psychotic side, and schizoaffective disorder and BD+ in the intermediate 
(Ghaemi et al., 2008).  
Auditory hallucinations occur in approximately 70% of SZ patients (Sommer, Koops, & 
Blom, 2012), and are said to be associated with reduced volume and increased activity of the 
superior temporal gyrus (STG), which contains the primary auditory cortex. These hallucinations 




suggests that individuals with BD may also have structural and functional abnormalities in the 
auditory cortex. However, these findings have been less consistent than in SZ, which may be 
partly attributed to the lack of consideration for the presence of psychotic features in previous 
study designs.  
Auditory processing deficits may contribute to impaired social interaction, as acoustic 
features of speech are used to identify emotional states in others (Juslin & Laukka, 2003). 
Individuals with SZ may have difficulty in recognizing affect from voice and facial expressions. 
Furthermore, basic tone discrimination ability is correlated with performance on auditory 
emotion recognition tasks, which has been related to reduced functional capacity in SZ (Gold et 
al., 2012). Given that some individuals with BD+ have structural and functional abnormalities in 
the auditory cortex, it would be expected that similar auditory processing deficits would be found 
in BD. Zenisek et al. (2015) examined this matter in BD+, SZ, and healthy controls. They found 
deficits in frequency discrimination and emotion recognition in both clinical groups. However, 
deficits were more severe in the SZ group, as compared to the BD+ and healthy control groups. 
These findings imply that auditory processing deficits in BD+ and SZ may contribute to deficits 
in the area of interpersonal functioning.  
 Research also suggests greater neurocognitive impairment in BD with psychosis (BD+) 
than BD without psychosis (BD-) and unique neurocognitive markers may aid in distinguishing 
the subtypes from one another (Martinez-Aran et al., 2008). Bora and colleagues (2010) 
conducted a meta-analysis of 14 studies, comparing patients with BD- to patients with BD+ on a 
number of cognitive variables (Bora, Yucel, & Pantelis; 2010). The BD+ had more inpatient 
admissions and a younger onset of illness as compared to the BD- group. BD+ patients also 




processing speed domains. The findings suggest that deficits related to working memory and 
executive functioning may represent a strong association between psychosis and frontal lobe 
abnormalities. However, the authors note that the effect sizes were small and psychosis alone 
could not explain neurocognitive deficits. Additional research is warranted in this area, given 
that similar neurocognitive deficits have been noted in BD+ and SZ, making it challenging to 
differentiate between the two disorders in clinical situations. In clinical settings, it may be more 
helpful to identify heterogeneous subgroups, as this may provide more insight into patient 
functioning, the optimal course of treatment, and prognosis.  
Activities of Daily Living and Functional Independence 
 Activities of daily living (ADLs), also referred to as physical ADLs or basic ADLs, are 
important skills needed to fulfill basic physical needs, and are activities that people tend do every 
day without needing assistance (Mlinac & Feng, 2016). Personal hygiene, dressing, toileting, 
walking, and eating are examples of ADLs. These skills are attained in early life and tend to be 
preserved in light of declined cognitive functioning, as compared to higher-level tasks. The 
ability to engage in personal care by carrying out ADLs is a core part of functional 
independence. The acquisition of these skills enables the individual to have an enhanced quality 
of life by promoting independence and self-efficacy, as well as decreasing caregiver burden. 
 Basic ADLs are differentiated from instrumental activities of daily living (IADLs), which 
are more complex tasks that are not necessary for fundamental functioning, but promote the 
individual’s ability to live independently within their community. These include grocery 
shopping, cooking, managing finances, managing medication, driving, chores and cleaning, and 
using the telephone or computer (Mlinac & Feng, 2016). As previously mentioned, 




IADLs. In particular, the neurocognitive impairments associated with BD and SZ may limit an 
individual’s ability to carry out basic tasks of self-care, as well as their capacity to live, function, 
and fully engage in their community (Mausbach et al., 2008). The neurocognitive impairments in 
SZ tend to be more severe than those observed in BD, and are associated with greater functional 
impairment (Bowie et al., 2010).  
 Deficits in everyday functioning skills in BD and SZ adversely impact the quality of life 
for individuals with these conditions. The World Health Organization considers BD and SZ as 
conditions that are likely to interfere with ability to reside independently, maintain an 
occupation, and consistently carry out daily living skills, such as personal hygiene, managing 
finances, and household chores (The World Health Organization, 2012). Notably, some 
individuals with these conditions are able to function well within their communities. However, it 
may be challenging for clinicians to determine their patients’ level of functioning because of 
limited time spent with the patient and lack of information about real-word functioning 
(Patterson, Goldman, McKibbin, Hughs, & Jeste, 2001). Several methods that have been 
developed to help clinicians and researchers determine functional capacity in psychiatric 
conditions like BD and SZ are reviewed below. 
Measurement of Functional Capacity Skills 
 It is often challenging to interpret the results of functional outcome studies because 
outcomes can be measured in several ways and measurement techniques are inconsistent across 
studies. Clinical variables like symptomatic recovery, number of episodes, the length of 
episodes, and number of hospitalizations may provide insight into the individual’s functioning 
(Martinez-Aran et al., 2008). However, these variables do not directly reflect the individual’s 




functioning: 1) self-report measures, 2) collateral informant reports (e.g., family members and 
caregivers), 3) clinician ratings, 4) in vivo observation of behavior in one’s place of residence, 
and 5) performance-based measures (Patterson et al., 2001).  
The aforementioned techniques are not without limitations. Self-report measures are 
prone to personal bias and may over- or under-estimate impairment levels on this domain. For 
example, ratings may be influenced by psychopathology in psychiatric patients. Collateral 
reports may be difficult to obtain, given that some individuals do not have a reliable person to 
provide information about their functional impairment (Patterson et al., 2001; Mausbach et al., 
2008). Ratings provided by clinicians or researchers may be based on very brief contact with the 
patient, a limited sample of behavior, and may not provide objective information about the 
ability to carry out everyday tasks in the real world. One such measure of clinician ratings is the 
Social-Adaptive Functioning Evaluation (SAFE) scale, which was developed for use in inpatient 
psychiatry units serving older adults (Harvey et al. 1997). While this scale may be useful for 
assessing behavior and function in inpatient settings, it is less useful for assessing community-
dwelling patients and younger age groups. Additionally, a clinician may not have enough 
information about a patient’s ability to carry out daily living skills in order to complete the scale. 
The Global Assessment of Functioning (GAF) rating scale has also been used to assess for 
functional outcomes in BD and SZ as they relate to educational, occupational, interpersonal, and 
self-care domains (APA, 2000). The GAF provides ratings of functioning based on the severity 
of psychiatric symptoms, functional impairment, or both. However, similar to the SAFE, GAF 
ratings are based on clinician ratings, so to the extent that the clinician’s knowledge of the 
individual is limited, ratings may not accurately represent the individual’s ability to carry out real 




 In laboratory and clinical settings, behavioral observation of one’s ability to carry out 
IADLs in real world settings is arguably the most direct and valid method for assessing 
functional capacity. Behavioral observations not only allow for determination of whether or not 
an individual can complete a particular task, but may also provide insight into the factors that 
interfere with successful performance. However, feasibility issues, such as cost and an extensive 
time commitment, make direct observation of real-world behavior a difficult technique to 
implement (Peterson et al., 2001).  
Thus, based on the aforementioned considerations, results of the many studies aiming to 
examine functional outcomes in SZ and BD have primarily relied on clinician ratings or self-
report measures are limited. In response to the limitation of self-reports, collateral reports, and 
direct observation assessment strategies, researchers have developed performance-based 
assessments to help improve feasibility and validity of functional assessment conducted in 
clinical or research settings. Use of performance-based measures present a number of attractive 
features, including less dependence on patient insight, which may be impaired in a severe 
psychiatric illness. An important consideration in the development of performance based 
methods to assess functional capacity is ecological validity, or the extent to which test content 
and items emulate real world tasks (Schmuckler, 2001).  
Performance based assessment methods have the advantage of using tasks that emulate 
the skills that a community-dwelling individual should possess to reside independently (e.g., 
dialing a telephone number, paying bills, grocery shopping). By using these methods, IADLs can 
be assessed in the laboratory using tasks that are similar, if not identical to, those required for 




measurement reliability, and increase validity by focusing on real-life skills that may be targets 
for interventions (Mausbach et al., 2008).  
One performance-based measure that has been validated for use in psychiatric 
populations is the University of California, San Diego (UCSD) Performance-Based Skills 
Assessment (UPSA; Patterson et al., 2001). There is a standard length and brief version of the 
scale (UPSA-B; Mausbach et al., 2010). The UPSA assesses skills across several domains: 
household chores, communication skills, finance management, transportation, and planning of 
recreational activities. Some studies have found that functional capacity measures like the UPSA 
are better predictors of real-world behaviors in social, vocational, and residential domains than 
cognitive performance or clinical variables (Bowie, Reichenberg, Patterson, Heaton, & Harvey, 
2006; Bowie et al., 2008).  
Control participants outperform individuals with SZ on the UPSA (Mausbach, Tiznado, 
Cardenas, Jeste, & Patterson, 2016; Patterson et al., 2001). Lower performance on the measure 
has been negatively correlated with impaired neurocognitive functioning and increased severity 
of negative symptoms in SZ (Patterson et al., 2001). Furthermore, many individuals with BD and 
SZ are unable to reside independently in their communities, and instead utilize assisted-living 
arrangements (Mausbach et al., 2010). The UPSA has shown to be a good predictor of living 
status in these populations (Mausbach et al., 2007; Mausbach et al., 2010).  In a study of middle-
aged and older adults with SZ, greater engagement in occupational and academic activities was 
associated with higher performance on the UPSA-B (Mausbach, Harvey, Goldman, Jeste, & 
Patterson, 2007). A similar study was conducted with older Hispanic adults with SZ, 
demonstrating a positive association between community involvement and UPSA performance 




impact of acculturation and education on UPSA performance among Hispanic participants. They 
also assessed for performance differences between a clinical group with psychosis (consisting of 
62 individuals with schizophrenia or schizoaffective disorder) and healthy controls. 
Acculturation and education were significant predictors of UPSA performance, and the clinical 
group performed worse on all UPSA subscales relative to the control group.   
It should be noted that the majority of performance-based studies examined functional 
outcomes in middle-aged and elderly patients with SZ, with fewer studies examining outcomes 
in BD. Mausbach and colleagues (2010) describe the need to examine functional outcomes in 
other debilitating psychiatric conditions, including BD. However, very few studies have actually 
examined the usefulness of these measures in understanding functional capacity in BD. 
Mausbach et al. (2010) assessed for outcomes in BD and SZ using the UPSA-B. Higher scores 
on the task were associated with better occupational functioning and ability to carry out everyday 
living tasks (assessed for with informant reports). Also notable, better UPSA-B performance was 
associated with greater residential independence in BD and SZ, regardless of age (Mausbach et 
al., 2010). 
 As previously mentioned, individuals with BD and SZ also demonstrate deficits in social 
and emotion processing, which is said to impact functional status. Thaler and colleagues (2014) 
examined the relationship between social cognitive factors and functional outcomes in BD+,  
BD-, and SZ. For the BD+ and SZ groups, the social/emotion processing factor was predictive of 
UPSA performance. The second factor (theory of mind) was only predictive of UPSA 
performance for the SZ group. The authors suggest that theory of mind may be better explained 
by a generalized cognitive deficit in SZ, whereas social/emotion processing may be related to 




importance of addressing emotion processing in individuals with a history of psychosis, as this 
may improve functional capacity. 
 BD and SZ groups differ in their pattern of neurocognitive performance, which suggests 
differences in the severity of functional impairment (Mausbach et al., 2010). Within these 
psychiatric illness groups, subgroups may also emerge. Identifying information about subgroups 
and their pattern of performance might inform clinical decisions and recommendations for 
patients and their families. Previous research has identified the utility of cluster analysis in 
effectively identifying subgroups of individuals who demonstrate differing patterns of 
neurocognitive functioning in a variety of psychiatric and neurological conditions (Allen & 
Goldstein, 2013). In a study of 136 patients with BD, Burdick and colleagues (2014) identified 
three clusters based on neurocognitive performance: globally impaired, selectively impaired, and 
neuropsychologically intact. In contrast, Bora et al. (2016) identified four subgroups in BD, 
including a severe impairment cluster, two moderately low-performance clusters, and a 
‘neuropsychologically normal’ cluster.  
 The most consistent findings on subgroups in SZ include a subgroup of individuals with a 
neuropsychologically normal profile, in addition to a subgroup with global and significant 
deficits and one to three intermediate subgroups with mixed cognitive deficits (Allen, Goldstein, 
& Warnick, 2003; Goldstein, Shemansky, & Allen, 2005; Kremen, Seidman, Faraone, Toomey, 
& Tsuang, 2004). In a study of 124 patients with SZ, Gilbert et al. (2014) identified three 
subgroups using cluster analytic techniques: a near-normal cognitive performance group, a group 
with global impairments, and a selectively impaired group, with specific deficits in processing 
speed and visual episodic memory. Patients in the selectively impaired group had better 




implications for the management of patients and for clinical trials since particular combinations 
of deficits in patients may influence treatment responses. These findings also suggest that while 
most individuals with SZ demonstrate significant global neurocognitive deficits, there is a 
subgroup of individuals with SZ who present with neurocognitive functioning that is similar to 
that of the general population.  
 To assess for subgroups based on levels of community functioning, Alden and colleagues 
(2015) used cluster analytic techniques. Community functioning was measured with the UPSA-
B, Social Skills Performance Assessment (SSPA), and Specific Levels of Functioning (SLOF). 
Their analysis revealed two distinct clusters, characterized by a high or low level of community 
functioning in SZ. The group with higher community functioning outperformed the low group on 
verbal working memory, but they did not differ on other neurocognitive domains (i.e., processing 
speed, attention, verbal learning, nonverbal working memory, and problem solving and 
reasoning). Control participants outperformed both SZ subgroups on all neurocognitive domains. 
The authors suggest that working memory may be an important domain for treatment, given the 
positive association between working memory and occupational functioning.  
 Strauss and colleagues (2013) used a cluster analytic approach and found evidence for 
two distinct subgroups based on negative symptoms in SZ: a group with predominantly 
Avolition-Apathy (AA) symptoms and another group with a profile most consistent with 
Diminished Expression (DE). The groups differed on functional capacity (as measured by the 
UPSA), as well as demographic, clinical course, and social cognition variables. AA was 
associated with poorer outcomes than DE, including worse performance on the UPSA. The 
studies mentioned above demonstrate the importance of identifying subgroups within psychiatric 




have implications for the application of appropriate assessment and intervention techniques 
based on this presentation.   
 Although evidence points to heterogeneity in functional outcomes in BD and SZ, very 
little research has assessed for subgroups based on UPSA performance within these psychiatric 
groups. Identifying subgroups based on functional capacity may have implications for treatment 
and predicting the course of the illness. Therefore, the current study aimed to investigate whether 
heterogeneity is present in functional abilities for individuals with SZ and BD. The study 
examined whether the heterogeneity is associated with other important and disorder specific 
domains identified in prior studies (i.e., demographics, IQ, and clinical symptoms). To 
accomplish this, we used a performance-based assessment (the UPSA) to evaluate individuals 
with SZ or BD.  Subscales from the UPSA were subjected to cluster analysis in order to compare 
clusters obtained in the BD group to the SZ group. The data were analyzed with three, four, and 
five cluster solutions for each group to determine optimal cluster solutions. Comparisons were 
also made between the SZ and BD clusters on demographic, clinical, and IQ variables to 
examine the external validity of the clusters. Clinically meaningful differences among the 
clusters on demographic, clinical, and IQ variables are important for treatment and 
outcome considerations. Based on the literature review, the current study identified the  
following hypotheses: 
Hypothesis 1: It was hypothesized that compared to controls, the BD and SZ groups 
would demonstrate functional impairment, with the SZ group demonstrating the greatest 




Hypothesis 2: It was hypothesized that distinct functional capacity profiles would be 
identified for both BD and SZ. It was anticipated that for each diagnostic group, three to 
five distinct functional capacity profiles would be identified.  
Hypothesis 3:  It was hypothesized that distinct functional profiles would be associated 
with other important outcomes (demographic, IQ, and clinical symptom variables). It was 
expected that participants who have impaired functional profiles would have significantly 
less education, lower IQ scores, greater negative symptoms, and less often married than 





Chapter 3: Methods 
Participants 
The present study utilized archival data from ongoing research studies conducted in the 
Neuropsychology Research Program (NRP) laboratory at the University of Nevada, Las Vegas 
(UNLV). The sample consisted of 250 adults with a primary diagnosis of BD (n = 129) or SZ (n 
= 71) and healthy controls (HC; n = 50). Participants were recruited using paper flyer postings, 
recruitment ads on Craiglist, public service announcements (over the radio on 91.5 KUNV FM, a 
local magazine called the View, and in the Las Vegas Review Journal), as well as from Mohave 
Mental Health Center in Las Vegas, NV and the Human Participant Pool at UNLV.  
Descriptive statistics for demographics of the entire sample can be found in Table 1. 
Univariate ANOVAs indicated that the SZ group was significantly older, F(2, 249) = 6.52, p = 
.002, had fewer years of education, F(2, 249) = 24.08, p < .001, and lower current IQ scores, 
F(2, 249) = 53.67, p < .001 than the BD and HC groups. An independent samples t-test found a 
marginally significant difference between the BD and SZ groups on number of hospitalizations, 
t(101.16) = -1.73, p = .09, d = .27.  
The groups did not significantly differ on handedness and marital status, ps > .05. 
However, were significant differences among the groups on ethnicity, χ2(10) = 29.21, p < .01, 
which was largely accounted by more representation of Caucasian participants in the BD group, 
as compared to the SZ and HC groups. There were also significant differences among the groups 
with regards to gender, χ2(2) = 7.67, p < .05, with the majority of the BD group being female, 
whereas the majority of participants in the SZ and HC groups were male. There were significant 
differences between the groups on employment status (with three levels: employed, student, 




SZ participants who were unemployed and not in an educational program (78.9%). Antipsychotic 
medication use was significantly higher for the SZ group (87.3%) than for the BD group 
(41.9%), χ2(1) = 46.88, p < .001. There were no significant differences between the psychiatric 
groups on their use of anti-depressant, anticonvulsant, and mood stabilizers.  
Exclusionary Criteria 
 Exclusion criteria included English as a secondary language, significant vision or hearing 
impairment (as determined by a brief screening process), a diagnosis of intellectual disability, a 
current or history of a neurological condition, a history of brain surgery, a current or prior 
traumatic brain injury, any significant head injury that led to a period of unconsciousness lasting 
more than a few seconds, and any history of a medical condition that is known to significantly 
affect the central nervous system (CNS), such as Huntington’s disease or Parkinson’s disease.   
Individuals were excluded from the study if they met criteria for a substance use disorder (within 
the last 6 months), as determined by the Structured Clinical Interview for the DSM-IV (SCID-
IV; First, Spitzer, Gibbon, & Williams, 1996). With the exception of medications prescribed for 
BD or SZ, current use of medications shown to affect CNS functioning was also an exclusion 
criterion.  
Procedure 
 Study procedures were approved by the UNLV Institutional Review Board (IRB) for the 
protection of human participants. Individuals interested in the study contacted the researchers by 
phone and were then administered a brief screening interview to determine eligibility. All phone 
screenings were first preceded by a verbal informed consent given over the phone. If participants 
met criteria, they were scheduled for an individual in-person interview and assessment. During 




administered a structured clinical interview using the SCID-IV. If the participant was deemed 
eligible by the researcher after the SCID-IV, the participant was then given a symptoms rating 
interview to determine current symptomatology. All researchers were trained to administer the 
SCID-IV, the UPSA, the symptoms rating scales, and the assessments. Two consent forms were 
signed and one was given to the participant and the other was kept in a locked filing cabinet in 
the NRP laboratory at UNLV. All questions that graduate researchers were unable to answer 
were directed to the principal investigator, Daniel N. Allen, PhD.  
Demographic Measures 
 Participant age, gender, years of education, employment status, marital status, 
medications, current IQ, and number of hospitalizations were used as demographic variables.  
Diagnostic Measure 
 Structured Clinical Interview for DSM-IV Axis 1 Disorders (SCID-IV). The SCID-IV 
(First et al., 1996) is a semi-structured interview designed to assess for DSM-IV Axis 1 
disorders. The SCID-IV has been extensively used in clinical populations to assess for both 
psychiatric and medical conditions found within the DSM-IV. The interview begins with a 
screener, which determines which modules to administer. Each module has a series of questions 
that rated on a scale of 1 to 3 (1 = no symptom, 2 = questionable whether symptom is present, 3 
= symptom is present). Depending on how the scoring of the interview proceeds, a DSM-IV Axis 
1 diagnosis may be made. The SCID-IV was used in our study to confirm a diagnosis of BD and 
SZ, rule out substance use disorders, and rule out psychopathology in the HC group. The SCID-
IV also provides the opportunity to estimate Global Assessment of Functioning (GAF) scores 





Measures of Functional Outcomes 
 The University of California, San Diego (UCSD) Performance-Based Skills 
Assessment (UPSA). The UPSA (Patterson et al., 2001) is a measure used to assess the ability to 
successfully carry out tasks that an individual is likely to encounter in their community. These 
tasks represent IADLs and require individuals to role-play these tasks. The UPSA was initially 
used with middle aged and elderly individuals with SZ (Patterson, et al., 2001).  
 There are five functional areas assessed by the UPSA: household chores (e.g., creating a 
shopping list of necessary ingredients to prepare a meal), communication skills (e.g., making a 
phone call to cancel and reschedule an appointment), finance management (e.g., writing a check 
to pay a utility bill), transportation (e.g., evaluating a bus schedule for transfer information and 
associated cost), and planning recreational activities (e.g., determining what items are necessary 
to bring on a beach outing).  
 The UPSA has been used to assess IADLs and to predict the ability of patients with 
disorders such as SZ (Mausbach et al., 2008), BD (Thaler et al., 2014), and dementias (Golder et 
al., 2010) to live independently in their communities. Raw scores on the UPSA are transformed 
into a 0 to 10 scale and then multiplied by 2. Five subscale scores are subsequently created (i.e., 
Communication, Planning, Household Chores, Finance Management, and Transportation) and 
range from scores of 1 to 20. Summary scores are calculated by summing the five subscale 
scores and range from 0 to 100.  The subscale scores were used in the current study’s analyses.  
 Global Assessment of Functioning (GAF). The GAF (APA, 2000) assesses 
psychological, social, and occupational functioning. The GAF score ranges from 0 – 100 based 
on 10-point increments. A score from 91 to 100 indicates superior functioning and no psychiatric 




psychiatric symptoms. Because GAF scores are based on functioning or symptoms, separate 
scores may be derived for functioning and symptoms.  The GAF Functioning score is determined 
based on the overall interpersonal, social, and occupational functioning of the individual. The 
GAF Symptomatology score is determined based on reported and observed symptom severity. 
For example, if a participant is depressed but holds a job and a good social support system, they 
would receive a higher GAF Functioning than Symptomatology score. In contrast, a participant 
with few friends and no job, but is relatively free of mood or psychotic symptoms would have a 
higher GAF Symptomatology than Functioning score.  
Clinical Symptom Measures  
 Hamilton Depression Rating Scale (HDRS). The HDRS (Hamilton, 1960) is a 17-item 
rating scale for depression. The HDRS assesses for depressed and anhedonic mood, associated 
cognitive symptoms of depression, and comorbid anxiety symptoms. Scores above 7 indicate the 
presence of depressive symptoms. The HDRS raw total score provides a good estimate of current 
depressive symptoms and was used in the study’s statistical analyses.  
Young Mania Rating Scale (YMRS). The YMRS (Young, Biggs, Ziegler, & Meyer, 
1978) is an 11-item rating scale for mania. The scale assesses for elevated mood, increased 
motor activity, increased sleep, irritability, and other common manic symptoms. Scores above 11 
indicate notable manic symptoms. The raw total score was used in this study.   
 Brief Psychiatric Rating Scale (BPRS). The BPRS (Overall & Gorham, 1962) is an 18-
item symptom rating scale designed to assess and evaluate symptoms associated with 
schizophrenia and other psychiatric disorders. A trained researcher rated and scored the BPRS 
after observing and interviewing each participant. A four-factor model (consisting of Thought 




the best fit for the factor structure of the BPRS (Muser, Curran, & McHugo, 1997). Scores based 
on this model were used in the current study.  
 Schedule for the Assessment of Positive Symptoms (SAPS). The SAPS (Andreasen, 
1984) is a clinician-reported evaluation of a patient’s positive symptoms associated with 
schizophrenia and psychosis in general. The items are categorized into DSM-IV recognized 
positive symptoms including Hallucinations, Delusions, Bizarre Behavior, and Formal Thought 
Disorder. These categories were used in the current study. Ratings are on a 6-point scale ranging 
from 0 (None) to 5 (Severe).  
 Schedule for the Assessment of Negative Symptoms (SANS). The SANS (Andreasen, 
1983) is a clinician-reported complement of the SAPS designed to evaluate negative symptoms 
associated with schizophrenia. Ratings are also on a 6-point scale ranging from 0 (None) to 5 
(Severe). Symptoms cluster into the five global ratings of symptoms (which were used in the 
current study), including Affective Flattening, Alogia, Avolition, Anhedonia, and Attention.  
Estimates of IQ 
 The Vocabulary (VO) and Block Design (BD) subtests of the WAIS-III (Wechsler, 1997) 
were administered in order to estimate current IQ functioning. The VO subtest contains 33 
vocabulary items which participants are asked to define. Items are rated as zero, one, or two 
depending on the answers. The BD subtest required participants to put together 11 progressively 
more difficult block designs using four or nine red and white blocks. Participants were scored 
based on the accuracy and speed in which they completed the task. Current IQ was calculated 
based on a regression equation designed to estimate Full Scale IQ using the VO and BD scaled 






Preliminary Analyses. Version 25 of the Statistical Package for the Social Sciences 
(SPSS) was used to analyze the data. Prior to conducting the primary analyses, the data were 
examined for outliers (i.e., extreme scores ± 3.0 standard deviations above or below the mean) 
using boxplots. After correction for outliers using Winsorization, skewness and kurtosis were 
also evaluated to ensure normality.  
Main Analyses. The approach of the current study was to cluster analyze scores from a 
test of functional capacity (the UPSA) to identify and compare subgroups or clusters in BD and 
SZ. Cluster analysis is an empirical statistical classification technique that allows for 
identification of subgroups based on similarities in a set of attributes. For this study, cluster 
analysis using the five UPSA subscale scores as attributes was used to examine subgroups within 
the BD and SZ groups. Data for three, four, and five cluster solutions were analyzed separately 
to determine the most parsimonious solutions for each group. Separate inspection of the optimal 
cluster solution for each group allowed for comparisons regarding the number and profiles of 
clusters unique to each group. The optimal cluster solutions were used to conduct between group 
comparisons on external validity variables. This also allowed for comparisons of the solutions 
based on level and pattern of performance differences between groups.  
Ward's method of cluster analysis was used because it produces results that are consistent 
with other agglomerative clustering methods and is less affected by outliers than other methods 
(Morris, Blashfield, & Satz, 1981). The squared Euclidian distance was used as the dissimilarity 
measure in the analyses because it is sensitive to differences in pattern and level of performance 
(Allen et al., 2010). Dendrograms were inspected to ensure the absence of chaining caused by 




 Identification of the appropriate number of clusters for the BD and SZ groups was 
identified using a number of methods.  First, stability of the cluster solutions derived using 
Ward's method was assessed for using the K-means iterative partitioning cluster analysis 
technique and discriminant function analysis (DFA). For K-means, the number of clusters and 
initial cluster centers were specified based on Ward's method results. K-means derives clusters 
by iteratively adding cases to the group that has the mean value closest to the unassigned data 
point (Hair, Black, Babin, Anderson, & Tatham, 1992). Cohen's kappa was used to assess the 
extent to which the K-means and Ward's method solutions agree. A high degree of 
correspondence between the two clustering methods provides evidence for the stability of the 
cluster solution.   
 DFA was also used to determine the ability of the UPSA variables to predict membership 
in the three, four, and five cluster solutions. Canonical discriminant function plots from the 
DFAs were used to examine the clusters in discriminant function space. For adequate cluster 
solutions, it was expected that separation of clusters would be present in discriminant function 
space. A high rate of predictive accuracy was also expected, such that the DFA would correctly 
classify most of the individuals into the clusters identified by Ward’s method.  
 Lastly, Beale’s F statistic (Beale, 1969) was used to compare the variance accounted for 
by each cluster solution based on the K-means analyses.  The F statistic is a measure of 
parsimony that allows for determination of whether there is a sufficient increase in the amount of 
variance accounted for as cluster solutions increase in complexity.  The cluster solution that 
demonstrated the highest degree of stability, predictive accuracy, and had the greatest parsimony 
as determined by Beale’s F was selected as the optimal solution. UPSA subscale scores were 




 Following identification of the optimal cluster solution for the BD and SZ groups, group 
comparisons were made on the external validity variables (i.e., demographic, clinical, and IQ 
variables). The general approach to the analyses involved utilization of group (SZ or BD clusters 
and HC) as a between-subjects variable, and the external validity variables as dependent 
variables. Group comparisons for sex, ethnicity, handedness, medications, marital status, and 
employment status were made using chi-square techniques. For continuous variables, analysis of 
variance approaches were used (univariate or mixed model ANOVAs).  
 Mixed model ANOVAs were used in cases where there are multiple related dependent 
variables and interaction effects were expected, as was the case for the IQ subtests, GAF 
Symptomology and Functioning scores, and clinical symptom variables. In these analyses, group 






Chapter 4: Results  
Cluster Analysis 
BD Cluster Analysis Results 
 Cluster analysis specified three, four, and five cluster solutions for both the BD and SZ 
groups with the five UPSA subscale scores as attributes in the analyses. For the BD group, 
results of the analyses are presented in Figure 1 (Frames A, B, and C). Stability of the cluster 
solutions was initially examined by discriminant function analysis (DFA). DFA correctly 
classified 97.7% of cases in the three-cluster solution, 93.0% of the cases making up the four-
cluster solution, and 90.7% of cases in the five-cluster solution.  
 The BD three-, four-, and five-cluster solutions identified using Ward’s method were then 
compared to clusters derived using K-means iterative cluster analysis using the centroids 
identified in Ward’s method as the initial clustering centers. Cohen’s kappas comparing 
agreement between the Ward’s and K-means derived the three-, four-, and five-cluster solutions 
were .87, .79, and .77, respectively. All of these values indicate substantial agreement (Landis, 
1977).  
 When graphed in discriminant function space, inspection indicated that all three of the 
cluster solutions exhibited adequate separation with little overlap between individual cases.  
Beale’s F indicated that the four-cluster solution did not account for more variance than the 
three-cluster solution (p > .05). The five-cluster solution did not account for more variance than 
the three- and four-cluster solutions (ps < .05). Considered together with the results of the DFAs, 
Cohen’s kappa values, and Beale’s test, the three-cluster solution was determined to be optimal 





SZ Cluster Analysis Results 
 For the SZ group, results of the three-cluster solutions are presented in Figure 2 (Frames 
A, B, and C). Stability of the cluster solutions was also examined with DFA to determine how 
well UPSA scores could predict cluster membership. DFA correctly classified 91.5% of cases in 
the three-cluster solution, 95.8% of the cases making up the four-cluster solution, and 98.6% of 
cases in the five-cluster solution.  
 The SZ three-, four-, and five-cluster solutions derived using Ward’s method were 
compared to clusters derived using K-means iterative cluster solutions using the centroids 
identified in Ward’s method as the initial clustering centers. Cohen’s kappa for the three-, four-, 
and five-cluster solutions were at .80, .76, and .85, respectively, with values all indicating 
substantial agreement (Landis, 1977). When graphed in discriminant function space, inspection 
indicated that all three-cluster solutions exhibited adequate separation with little overlap between 
individual cases.  
 Furthermore, Beale’s F indicated that the four-cluster solution did not account for more 
variance than the three-cluster and five-cluster solutions solution (ps > .05). The five-cluster 
solution accounted for more variance than the three-cluster solution (p < .05). A five-cluster 
solution was determined to be the optimal solution for the SZ based on the DFA, kappa values, 
and Beale’s results.   
Standardized Scores for the UPSA 
The final cluster solutions for the BD and SZ groups in comparison to controls are 
presented in Figure 3 (Frames A and B). For this figure, the mean and standard deviation for the 
HC group on each of the UPSA subscales were used to calculate standard scores (i.e., z scores) 




the HC group on Planning, Finance Management, and Communication. On Household Chores, 
Cluster 1 performed almost one standard deviation above the HC group, whereas Cluster 2 
performed slightly more than 1 standard deviation below the HC group. Therefore, names for 
these clusters were given based upon their Household Chores performance (High Average 
Household Chores and Low Average Household Chores). For the BD group, Cluster 3’s 
performance was similar to the HC group on Household Chores. Their performance was slightly 
better than the HC group on Planning and Communication and slightly lower on Finance 
Management. However, Cluster 3’s performance on Transportation was more than 2.5 standard 
deviations below the HC group. Thus, Cluster 3 was called Impaired Transportation.  
For the SZ group, Cluster 1’s performance was similar to that of the HC group. 
Therefore, Cluster 1 was referred to as the Normal Functioning cluster. Performance for Clusters 
2 and 3 fell in the low average range, with each cluster demonstrating selective impairments in 
different domains. Cluster 2 was selectively impaired on Transportation, and Cluster 3 was 
selectively impaired on Finance Management. Therefore, Cluster 2 was called Impaired 
Transportation and Cluster 3 was named Impaired Finance Management.  
SZ Cluster 4 demonstrated the most impairment, with scores at least 2 standard 
deviations below the HC group. Their worst score (5 standard deviations below controls) was on 
Finance Management. This cluster was called Severely Impaired due to impairments across all 
UPSA domains relative the HC group. Lastly, when compared to HC performance, Cluster 5 
scored approximately 1 standard deviation below on Transportation and Household Chores, 2 
standard deviations below on Communication, 3 standard deviations below on Finance 




performance, which was somewhat better than the Severely Impaired cluster, Cluster 5 was 
called the Moderately Impaired cluster.  
Group Comparisons on the UPSA (BD, SZ, and HC) 
 A mixed model ANOVA was conducted to examine differences among BD and SZ 
clusters and the HC group on each of the UPSA subscales. In the analysis, group served as a 
between subjects variable with 10 levels (three BD clusters, five SZ clusters, and HC) and UPSA 
performance (with five levels: Planning, Finance Management, Communication, Transportation, 
and Household Chores) as a within subjects variable. Results indicated main effects for group, 
F(8, 241) = 41.18, p < .001, ηp2  = .58 and UPSA performance, F(3.95, 950.73) = 36.13, p < .001, 
ηp2  = .13. A significant group by UPSA interaction was also observed, F(31.56, 950.73) = 18.51, 
p < .001, ηp2 = .38.  
 A post-hoc Tukey's B test indicated that SZ Cluster 5 (the Moderately Impaired cluster) 
had the lowest score on Planning, with all other BD and SZ clusters and the HC group 
outperforming them on this domain. On the Communication subscale, all BD clusters, SZ 
Clusters 1 and 5 (Normal Functioning and Moderately Impaired clusters), and the HC group 
significantly outperformed SZ Clusters 2 and 4 (Impaired Transportation and Severely Impaired 
clusters). With regards to Finance Management, Transportation, and Housing, the Severely 
Impaired cluster in SZ had significantly lower performance than all other BD and SZ clusters 
and the HC group.  Notably, the HC group and BD Cluster 1 (High Average Household Chores) 
did not differ on any of the UPSA subscales. The HC group and the Normal Functioning cluster 
in SZ significantly differed on only one subscale, with the HC group demonstrating better 
performance on Household Chores. Descriptive statistics and post hoc comparisons for UPSA 




Cluster Comparisons on External Validity Variables 
Demographic Differences between Clusters and HC group 
 Descriptive statistics for demographic comparisons between BD clusters and the HC 
group are found in Table 3. There were no significant differences among BD clusters and the HC 
group with regards to age, years of education, marital status, current IQ, handedness, ethnicity, 
and gender (all ps > .05).  There were no significant differences between BD clusters on 
medication status, p > .05. There were significant differences on employment status (with three 
levels: employed, student, unemployed), χ2(6) = 20.81, p < .01. These differences were 
accounted for by a higher percentage of the HC group being employed or involved in an 
educational program (78%) when compared to the BD clusters (52.7%).  
 Descriptive statistics for demographic comparisons between SZ clusters and the HC 
group are found in Table 4. There were no significant differences in age, handedness, marital 
status, ethnicity, and gender between the SZ clusters and HC group, ps > .05. There were no 
significant differences between SZ clusters on medication status, p > .05. However, there were 
significant differences in years of education, F(5, 120) =  8.10, p < .001, and current IQ scores, 
F(5, 120) = 22.40, p < .001. A post-hoc Tukey’s B test indicated that all clusters (with the 
exception of the Normal Functioning cluster) had significantly fewer years of education and 
lower current IQ scores than the HC group. The Severely Impaired cluster had significantly 
lower current IQ estimates than the Normal Functioning and Impaired Transportation clusters 
(who did not differ from one another). There were significant differences between the groups on 
employment status (with three levels: employed, student, unemployed), χ2(10) = 46.27, p < .001. 




paid employment or were not involved in an educational program. Also notable, every member 
of the Severely Impaired cluster was unemployed, which also accounted for this difference.  
 Clinical Symptom Variables (BD Clusters and HC) 
 Descriptive statistics and post hoc comparisons for clinical symptom variables for BD 
clusters and the HC group are presented in Table 5. Comparisons on BPRS data were made using 
mixed-model ANOVAs, with BPRS (Affective Flattening, Anergia, Disorganization, and 
Thought Disorder) as a within subjects variable and group as the between subjects variable. 
Results indicated main effects for group, F(3, 175) = 22.45, p < .001, ηp2 = .28 and BPRS scores, 
F(1.99, 348.11) = 284.51, p < .001, ηp2 = .62, as well as a significant group by BPRS interaction, 
F(5.97, 348.11) = 8.62, ηp2 = .13. A post-hoc Tukey's B analysis found that the HC group had 
significantly lower scores on the BPRS Thought Disorder and Affective Flattening subscales 
than all BD clusters. On the Anergia subscale, the HC group had significantly lower scores than 
Low Average Household Chores and Impaired Transportation, whereas HC and Cluster 1 did not 
significantly differ. There were no significant differences between the BD clusters on Anergia. 
Low Average Household Chores had significantly higher scores on the Disorganization subscale, 
when compared to HC and the other two BD clusters.  
 A mixed model ANOVA was also used to analyze GAF data, with GAF (Functioning and 
Symptomology) serving as a within subjects variable and group serving as a between subjects 
variable. There was a significant main effect for group, F(3, 174) = 52.61, p < .001, ηp2 = .48, but 
not for GAF, p > .05, ηp2 = .001. There was a significant group by GAF cross-over interaction, 
F(3, 174) = 6.23, p < .001, ηp2 = .10. A post-hoc Tukey's B analysis revealed that the HC group 
had significantly higher GAF Symptomology scores than all BD clusters (who did not 




symptoms. High Average Household Chores had a significantly higher GAF Functioning score 
when compared to Low Average Household Chores. The Low Average Household Chores and 
Impaired Transportation clusters did not significantly differ on GAF Functioning. A one-way 
ANOVA with a Tukey’s B post-hoc analysis demonstrated that the HC group had significantly 
lower HDRS (F[3, 175] = 20.78, p < .001) and YMRS scores (F[3, 175] = 11.06, p < .001) than 
all BD clusters (who did not significantly differ from one another).  
 Clinical Symptom Variables (SZ Clusters and HC) 
 Descriptive statistics and post hoc comparisons for clinical variables for SZ clusters and 
HC can be found in Table 6. Comparisons on BPRS data were made using a mixed-model 
ANOVA, with BPRS (Affective Flattening, Anergia, Disorganization, and Thought Disorder) as 
a within subjects variable and group as the between subjects variable. Results indicated main 
effects for group, F(5, 115) = 30.25, p < .001, ηp2 = .57 and BPRS scores, F(2.79, 321.16) = 
80.07, p < .001, ηp2 = .41, as well as a significant group by BPRS interaction, F(13.96, 321.16) = 
7.68, ηp2 = .25.  
A post-hoc Tukey's B test found that all SZ clusters had significantly higher scores on the 
BPRS Thought Disorder subscale than the HC group. The Severely Impaired cluster had 
significantly higher scores on BPRS Anergia, when compared to all other SZ clusters. The HC 
group did not differ from the Normal Functioning, Impaired Transportation, and Impaired 
Finance Management clusters on Anergia. The Normal Functioning and Impaired Transportation 
clusters scored significantly higher than the HC group on the Affective Flattening subscale. 
However, there were no significant differences between the BD clusters on Affective Flattening. 
On the Disorganization subscale, the Moderately Impaired cluster scored significantly higher 




 A mixed model ANOVA was used to analyze SAPS and SANS data for the SZ clusters 
and HC group. Significant main effects for group, F(5, 115) = 23.09, p < .001, ηp2 = .50 and 
SAPS, F(2.55, 293.61) = 37.05, p < .001, ηp2  = .24 were found. There was a significant 
interaction effect between group and SAPS scores, F(12.77, 293.61) = 88.06, p < .001, ηp2 = .20. 
Significant main effects for group, F(5, 115) = 14.59, p < .001, ηp2 = .39 and SANS scores,  
F(2.26, 260.61) = 33.00, p < .001, ηp2  = .22, were also found. In addition, a significant 
interaction effect between group and SANS scores was found, F(11.33, 260.61) = 4.37, p < .001, 
ηp2 = .16. 
 A comparison of SZ clusters and HC on GAF data was made using a mixed model 
ANOVA, which yielded significant main effects for group, F(5, 114) = 120.09, p < .001, ηp2 = 
.84, and GAF, F(1, 114) = 33.51, p < .001, ηp2 = .23. A group by GAF interaction was 
determined to be significant, F(5, 114) = 8.09, p < .001, ηp2 = .26. A Tukey’s B post-hoc analysis 
revealed that the HC group had higher GAF Functioning and Symptoms scores when compared 
to all SZ clusters (who did not significantly differ on either subscale).  
 IQ Differences (BD Clusters and HC) 
 Descriptive statistics and post hoc comparisons on IQ variables for BD clusters and HC 
are presented in Table 4. IQ comparisons for the three-cluster BD solution and the HC group 
were accomplished using a mixed-model ANOVA with IQ (Block Design and Vocabulary) as 
the within subjects variable and group as the between subjects variable. Results indicated a 
significant main effect for IQ test, F(1, 175) = 47.91, p < .001, ηp2 = .22, but not for group, p > 
05, ηp2 = .03. There was a marginally significant group by IQ cross-over interaction, F(3, 175) = 





 IQ Differences (SZ Clusters and HC) 
 Descriptive statistics and post hoc comparisons on IQ variables for SZ clusters and HC 
are presented in Table 6. A mixed model ANOVA was used to analyze IQ data for the five-
cluster SZ solution and HC group. Results indicated a significant main effect for group, F(5, 
115) = 23.09, p < .001, ηp2 = .50, but not IQ, p > .05, ηp2 = .01. A post-hoc Tukey's B analysis 
demonstrated that the HC group had significantly higher Vocabulary scores than all SZ clusters, 
with the exception of the Normal Functioning cluster. The Normal Functioning cluster had a 
significantly higher mean Vocabulary score when compared to the Moderately and Severely 
Impaired clusters. On Vocabulary, the Normal Functioning, Impaired Transportation, and 
Impaired Finance Management clusters did not differ, and all other clusters and the HC group 
outperformed the Severely Impaired cluster on this domain. On Block Design, the HC group 
outperformed all SZ clusters, with the exception of the Normal Functioning cluster. Similar to 
Vocabulary, the Normal Functioning, Impaired Transportation, and Impaired Finance 
Management clusters did not significantly differ on Block Design. However, they outperformed 





Chapter 5: Discussion 
 The current study examined heterogeneity in functional capacity by cluster analyzing 
UPSA scores in adults living with a serious mental illness (i.e., BD or SZ). The goals were to 
determine whether: 1) subgroups could be identified in BD and SZ based on individual 
differences in functional capacity, as measured by a performance based measure of functional 
abilities (the UPSA), 2) similar functional capacity profiles would be present in BD and SZ, and 
3) the extent to which the external validity of the cluster solutions would be supported by 
meaningful differences on demographic, clinical, and IQ variables, which play a significant role 
in identifying prognosis and treatment in SMIs. UPSA scores were separately cluster analyzed 
for each psychiatric group. The UPSA was selected as a measure of functional capacity, given its 
utility in assessing this outcome in previous studies with BD and SZ (Cardenas et al., 2008; 
Mausbach et al., 2010; Mausbach et al., 2016).  
 After the optimal cluster solution was selected (three-solution for BD and five-solution 
for SZ), the clusters were compared to healthy controls on functional outcomes, clinical 
variables, and IQ scores. Results demonstrated that clusters were differentiated primarily by 
pattern of performance in the clinical groups and there were differences between the psychiatric 
groups in the number of clusters identified. Normal clusters were identified in both clinical 
groups. However, the SZ group demonstrated greater overall impairment compared to BD and 
healthy controls. For adults with BD or SZ, cluster membership was associated with differences 
on a number of outcome variables, supporting the external validity of the cluster solutions. The 
current findings provide support for the idea that there is substantial heterogeneity in functional 




domains, given that significant differences between psychiatric clusters and the HC group were 
found on UPSA subscale scores and external validity variables.  
 The three-cluster solution was determined to be optimal for the BD group. Two normal 
performance clusters (High Average Household Chores and Low Average Household Chores) 
were identified. Their pattern of performance resembled the HC group, with relatively flat 
performance profiles across four of five subscales. On Household Chores, the High Average 
Household Chores and HC group significantly outperformed the Low Average Household 
Chores cluster. Cluster 3 was called Impaired Transportation as a result of their low 
Transportation scores, which fell almost three standard deviations below the HC group. Notably, 
the Impaired Transportation cluster did not significantly differ from the other BD clusters and 
HC on any other UPSA domains. The BD clusters and HC group did not differ on demographic 
variables including age, years of education, marital status, current IQ, handedness, ethnicity, and 
gender. The BD clusters did not differ on number of hospitalizations or medication status. 
Examination of external validity variables demonstrated relatively few differences between the 
clusters. One important finding was that the High Average Household Chores Average cluster 
had a significantly higher GAF score when compared to the Low Average Household Chores 
cluster. These two clusters were also primarily differentiated by performance on the UPSA 
Household Chores domain, which consists of a planning component. This implies an association 
between planning skills (with regards to managing a household) and overall functioning, as 
reflected by the GAF.  
From a more general perspective, the results suggest that functional capacity (as 
measured by the UPSA) is relatively well preserved in individuals with BD given that 76.0% of 




Household Chores). Even Cluster 3, which had a marked deficit on Transportation, demonstrated 
relatively well-preserved functioning in the other domains assessed by the UPSA.  It may be that 
more differences would have been identified between BD clusters and the HC group if a more 
demanding functional capacity task were used, given that the majority of BD participants 
performed within normal limits. However, subtle differences, if present, could still negatively 
impact functioning and would help explain the relatively high degree of disability experienced in 
BD.  Along these lines, there were significant differences between the BD clusters and HC group 
on the other measure of functioning included in this study (GAF Functioning). Controls obtained 
a mean score of 82 which indicates good functioning in all areas, while the BD clusters obtained 
mean scores ranging from 59.7 to 66.5, which indicates some difficulty in at least one functional 
domain (social, occupational, or academic functioning). While there is some overlap in the 
domains assessed by the UPSA and GAF, the GAF reflects more general areas of functioning 
that most likely require functional and other abilities that are not included on the UPSA. 
 It is also important to note that participants in this study were euthymic at the time of 
testing. Furthermore, their average scores on measures of mania and depression were relatively 
low and generally below standard cutoffs. Individuals in active mood episodes are anticipated to 
evidence greater functional impairment than found in the current sample. Research has also 
shown that there is greater inter-episode recovery for BD compared to SZ (Bora & Pantelis, 
2015). When not experiencing an active mood episode, many individuals with BD are at normal 
or near normal levels of functioning.  In contrast, severe residual symptoms characteristic of SZ 
continue to interfere with functioning even when individuals are not in an active psychotic 
episode.                  




functional capacity profiles identified. Cluster 1 was determined to have normal functioning 
given that their scores did not significantly differ from the HC group. The Normal Functioning 
cluster demonstrated less evidence of positive and negative symptoms when compared to other 
clusters, and did not significantly differ from the HC group on IQ, depression, and mania scores. 
Identification of a normal functioning cluster is consistent with neuropsychological studies of 
schizophrenia that have also identified a group of individuals who demonstrate cognitive abilities 
that are within normal limits. This group of individuals has been previously referred to as 
“neuropsychologically normal” or “high functioning.” However, with closer examination, subtle 
deficits consistent with the neurocognitive profile identified in more severely impaired 
individuals with SZ can be found (e.g., Allen et al., 2003; Gilbert et al., 2014; Kremen et al., 
2004; Palmer et al., 1997). In those studies, neuropsychologically normal clusters have made up 
from 19.5% to 43% of the samples. In the current study, 32.4% of participants performed within 
normal limits on all UPSA subscales. The implications of a normal functioning schizophrenia 
group, as demonstrated through the use of a functional measure like the UPSA has not been 
extensively investigated. However, given that better neurocognitive abilities predict better 
functioning, it may be expected that individuals in this UPSA cluster would also demonstrate 
less impairment across other important domains. Consistent with this suggestion, this cluster had 
higher IQ and lower symptoms scores. Whether differences in treatment response, disease 
course, or neurobiology are also present requires additional investigation. 
Two low average groups with selective impairments were identified (Impaired 
Transportation and Impaired Finance Management). Like the normal UPSA cluster, they 
demonstrated fewer positive and negative symptoms compared to the more severely impaired 




depression scores. However, both low average clusters had significantly lower IQ scores when 
compared to the HC group. 
The fourth cluster was found to be severely impaired across all UPSA domains. The 
Severely Impaired cluster demonstrated more negative and positive symptoms, higher depression 
and mania scores, and more impairment on neurocognitive measures (i.e., Block Design and 
Vocabulary subtests of the WAIS-III), as compared to controls and other clusters. This cluster 
compromised 7% of the sample. This estimate is slightly lower than neuropsychological studies 
that have identified a severely impaired cluster, consisting of 14-19% of their samples (e.g., 
Gilbert et al., 2014; Goldstein, 1990; Kremen et al., 2004).  This cluster is likely comprised of 
individuals with SZ who will require ongoing support and may be unable to reside independently 
(The World Health Organization, 2012). The increased severity of their symptoms suggests that 
they are less likely to respond to psychosocial and medication interventions than the other 
clusters. There also appears to be a compounding of affective and psychotic symptoms in the 
Severely Impaired cluster.  However, it is less likely that they have schizoaffective disorder, 
given that this population is at a lower risk for severe neurocognitive impairments (Goldstein et 
al., 2005). It is more likely to be the case that increased affective and psychotic symptoms in 
these individuals are best explained by a severe course and presentation of SZ.   
Lastly, a Moderately Impaired cluster (C5) was identified, with this group demonstrating 
significant weaknesses on Planning, Finance Management, and Communication. The moderately 
impaired group (C5) in SZ had lower IQ scores as compared to the HC group and Normal 
Functioning group (C1). This cluster had significantly higher Delusion scores on the SAPS when 
compared to all other clusters. They also demonstrated more thought disorder symptoms and 




 Also notable, the SZ clusters and HC group did not differ on age, marital status, 
handedness, ethnicity, and gender. The SZ clusters did not differ on medication status or number 
of hospitalizations. However, there were significant differences on current IQ and years of 
education, with the HC group having more years of education and higher current IQ estimates 
than all clusters, with the exception of the Normal Functioning cluster. These differences in 
education and IQ are expected because those variables are strongly associated with the diagnosis 
of schizophrenia.  
Limitations  
 The current study is not without limitations. Functional capacity and performance on 
neurocognitive measures were generally within normal limits for the BD group, implying that the 
current sample is functioning well when compared to other studies with BD samples. Participants 
were excluded if they were experiencing an active mood state. Therefore, participants were in a 
euthymic mood state, which may have contributed to their generally normal performance on the 
UPSA and other external validity variables. Exclusion criteria of current substance use or abuse 
diagnoses may have excluded lower functioning individuals from all groups, resulting in nearly 
the majority of the sample (48.8%) consisting of individuals who are working and/or attending 
college. Recruitment of a community dwelling sample may have also produced a higher 
functioning sample than what might have been obtained from recruiting primarily from mental 
health facilities.  
 Furthermore, additional participants would have increased the power in the study and 
may have resulted in more significant findings. Ceiling effects may have also influenced results 
in the current study. It may be that the UPSA was not challenging enough to pick up on subtle 




UPSA assesses many important functional domains but is not comprehensive, so there may be 
other functional abilities that could be studied to determine optimal cluster solutions. 
Implications and Future Directions 
 This study advanced the literature by examining heterogeneity in functional capacity 
among the most common SMIs (i.e., BD and SZ). Identifying subgroups based on functional 
capacity may have implications for tailored treatment approaches and prognosis considerations. 
The findings regarding education and IQ in BD and SZ suggest further evidence for 
neuropsychologically normal groups within both psychiatric illness groups (Allen et al., 2003; 
Bora et al., 2016; Burdick et al, 2014; Černis et al., 2015; Goldstein, 1990; Kremen et al., 2004; 
Palmer et al., 1997). The findings are also consistent with previous research that has established 
the link between higher intellectual functioning and better functional outcomes in BD and SZ 
(Černis et al., 2015; Forcada et al., 2015). Notably, there were fewer subgroups identified in BD 
than SZ, which implies that there may be less heterogeneity in functional capacity in BD. The 
BD clusters followed a similar pattern of performance as the HC group, with the exception of the 
Impaired Transportation cluster, who only demonstrated a selective impairment on the 
Transportation domain. Findings are also consistent with research that has demonstrated better 
functional capacity in BD as compared to SZ (Mausbach et al., 2010), as moderately and 
severely impaired groups were identified in the SZ sample and these were not present in BD. 
 It should be noted that previous research on functional capacity has been complicated by 
poor measurement techniques, which may not accurately capture one’s strengths and 
weaknesses. Therefore, a major strength of the current study is the use of a validated 
performance based measured called the UPSA (Patterson et al., 2001). It is recommended that 




disorders utilize performance-based measures in addition to traditional methods (e.g., self- and 
collateral-report, clinician observation). However, it is possible that a more complex functional 
capacity task may be more useful in assessing for heterogeneity in BD, particularly among 
individuals in a euthymic mood state. Future research is also warranted to examine how 
performance-based measures may be used to assess for changes in functional capacity in 
response to interventions (e.g., medication, cognitive remediation, social skills training, cognitive 
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Table 1. Descriptive Statistics for Demographics of Entire Sample  
 
Note: Current IQ estimates were calculated using WAIS-III Vocabulary and Block Design 
subtest scores and regressed on the equation developed by Ringe and colleagues (2002).
Variable BD 
n = 129 
SZ 
n = 71 
HC 
n = 50 
p 
Age (M, SD) 35.75 (13.08) 42.59 (12.19) 36.76 (14.18) .002 
Education (M, SD) 14.14 (2.29) 12.00 (2.01) 14.04 (2.07) <.001 
Marital Status (%)    .68 
Never Married 45.7 60.6 44.0  
In a relationship 14.0 11.3 18.0  
Married 17.1 9.9 14.0  
Divorced 14.7 9.9 14.0  
Separated 7.8 5.6 8.0  
Widowed 0.8 2.8 2.0  
Employment Status (%)    <.001 
Paid Employment 40.3 19.7 46.0  
Student 12.4 1.4 32.0  
Unemployed 47.3 78.9 22.0  
Medication Status     
Mood Stabilizers 12.4 7.0 -- .29 
Antipsychotics 41.9 87.3 -- <.001 
Anticonvulsants 39.5 28.2 -- .18 
Antidepressants 39.5 50.7 -- .13 
Hospitalizations (M, SD) 2.18 (3.00) 3.25 (4.76) -- .08 
Female (%)  63.6 43.7 52.0 .02 
Ethnicity (%)    .001 
Caucasian  76.0 56.3 56.0  
African American 5.4 22.5 18.0  
Hispanic/Latino 5.4 11.3 8.0  
Asian American 3.9 1.4 14.0  
Mixed/Bi-Racial 6.2 5.6 4.0  
    Other 3.1 2.8 0.0  




Table 2. Descriptive Statistics (Means and Standard Deviations) and Post-Hoc Results for the UPSA (all Clusters and HC group)  
Note: BD C1 = High Average Household Chores Cluster; BD C2 = Low Average Household Chores Cluster; BD C3 = Impaired 
Transportation Cluster; SZ C1 = Normal Functioning Cluster; SZ C2 = Impaired Transportation Cluster; SZ C3 = Impaired Finance 
Management Cluster; SZ C4 = Severely Impaired Cluster; SZ C5 = Moderately Impaired Cluster. * p < .001 = significant differences 
on the following domains:  
Planning: HC, BD C1-C3, SZ C1-C4 > SZ C5; HC, BD C1, BD C2, BD C3 > SZ C4;  
Finance Management: HC, BD C1, BD C2, SZ C1 > SZ C2-C5; BD C3, SZ C2 > SZ C3-C5; SZ C3, SZ C5 > SZ C4; 
Communication: HC, BD C1, BD C3, SZ C1 > SZ C2, SZ C4, SZ C5; BD C2, SZ C3 > SZ C4, SZ C5; SZ C2 > SZ C4; BD C3 > SZ 
C3 
Transportation: HC, BD C1, SZ C1, SZ C3 > BD C3, SZ C2, SZ C4, SZ C5; BD C2, SZ C5 > BD C3, SZ C2, SZ C4;  
BD C3, SZ C2 > SZ C4 
Housing: HC, BD C1-C3, SZ C1-C3, SZ C5 > SZ C4; BD C1 > HC, SZ C1; HC, BD C1, BD C3, SZ C1, SZ C2, SZ C3 > BD C2, SZ 
C4, SZ C5 
Group Planning* Finance Management* Communication*  Transportation* Household Chores* 
BD       
C1 18.00 (1.80) 17.47 (2.56) 16.32 (2.87) 17.60 (2.37) 19.92 (.64) 
C2 17.86 (1.84) 17.68 (1.83) 15.51 (2.85) 16.88 (2.79) 13.88 (2.46) 
C3 18.85 (1.06) 16.55 (2.76) 17.78 (1.91) 10.83 (2.13) 17.50 (3.04) 
SZ      
C1 17.20 (2.34) 17.47 (1.42) 16.62 (2.77) 18.26 (1.70) 16.52 (3.18) 
C2 16.49 (2.72) 14.78 (3.44) 13.21 (3.27) 10.71 (3.39) 17.63 (2.57) 
C3 16.85 (1.98) 10.56 (2.42) 13.89 (3.69) 18.06 (1.72) 18.75 (2.26) 
C4 15.26 (2.90) 7.29 (.84) 9.33 (2.43) 7.40 (3.58) 8.60 (.89) 
C5 12.96 (2.18) 11.05 (2.37) 10.93 (2.00) 14.72 (2.23) 13.59 (2.61) 




Table 3. Descriptive Statistics for Demographics for BD Clusters and HC group  
 
Note: C1 = High Average Household Chores Cluster  
C2 = Low Average Household Chores Cluster 
C3 = Impaired Transportation Cluster 
 BD C1 
n = 61 
BD C2 
n = 48 
BD C3 
n = 20 
HC 
n = 50 
p 
Age (M, SD) 34.38 (12.80) 37.31 (12.31) 36.20 (15.72) 36.76 (14.18) .68 
Education (M, SD) 14.39 (2.49) 13.94 (2.04) 13.88 (2.28) 14.04 (2.07) .68 
Marital Status (%)     .95 
Never Married 44.3 39.6 65.0 44.0  
In a relationship  14.8 14.6 10.0 18.0  
Married 14.8 20.8 15.0 14.0  
Divorced 14.8 16.7 10.0 14.0  
Separated 9.8 8.3 0.0 8.0  
Widowed 1.6 0.0 0.0 2.0  
Employment Status 
(%) 
    .002 
Paid 
Employment 
52.5 29.2 30.0 46.0  
Student 8.2 16.7 15.0 32.0  
Unemployed 39.3 54.2 55.0 22.0  
Medication Status      
Mood Stabilizers 11.5 12.5 15.0 -- .92 
Antipsychotics 37.7 43.8 50.0 -- .59 
Anticonvulsants 42.6 33.3 45.0 -- .53 
Antidepressants 42.6 35.4 40.0 -- .75 
Female (%)  67.2 60.4 60.0 52.0 .45 
Ethnicity (%)     .10 
Caucasian  77.0 75.0 75.0 56.0  
African 
American 
1.6 8.3 10.0 18.0  
Hispanic/Latino 4.9 6.3 5.0 8.0  
Asian American 6.6 2.1 0.0 14.0  
Biracial 4.9 6.3 10.0 4.0  
    Other 4.9 2.1 0.0 0.0  
Handedness (%)     .22 
Right  91.7 79.2 80.0 94.0  
Left 6.7 18.8 15.0 6.0  
























Note: BPRS = Brief Psychiatric Rating Scale; GAF = Global Assessment of Functioning; HDRS = Hamilton Depression Rating Scale; 
YMRS = Young Mania Rating Scale; Current IQ estimates were calculated using WAIS-III Vocabulary and Block Design subtest 
scores and regressed on the equation developed by Ringe and colleagues (2002); C1 = High Average Household Chores Cluster; C2 = 
Low Average Household Chores Cluster; C3 = Impaired Transportation Cluster 
 
Variable (M, SD) 
 
BD C1 
n = 61 
BD C2 
n = 48 
BD C3 
n = 20 
HC 
n = 50 
p Tukey’s B 
BPRS        
Affect 10.39 (3.23) 11.85 (4.14) 10.20 (3.81) 7.00 (2.56) <.001 HC < C1, C2, C3 
Anergia 4.82 (1.47) 5.27 (2.26) 5.50 (1.79) 4.28 (.95) .008 HC < C2, C3 
Disorganization 3.51 (.87) 4.41 (1.76) 3.65 (1.09) 3.32 (.82) <.001 HC < C2 
Thought Disorder 5.03 (1.58) 5.38 (1.97) 5.00 (1.65) 4.16 (.51) .001 HC < C1, C2, C3 
GAF       
Functioning 66.54 (11.40) 59.69 (12.25) 63.90 (10.59) 81.98 (9.42) < .001 HC >  C1, C2, C3; 
C1 > C2 
Symptomology 63.07 (9.80) 60.04 (10.01) 64.25 (10.54) 83.96 (8.60) < .001 HC >  C1, C2, C3 
HDRS 8.20 (5.34) 9.98 (6.16) 9.30 (6.90) 2.28 (3.04) < .001 HC <  C1, C2, C3 
YMRS 3.26 (2.79) 4.98 (4.57) 3.85 (4.92) .98 (2.19) < .001 HC <  C1, C2, C3 
Hospitalizations 2.16 (2.79) 2.15 (3.15) 2.30 (3.33) -- .98  
IQ       
Block Design 10.70 (3.39) 9.81 (2.84) 9.00 (2.58) 10.92 (2.78) .04 HC > C3 
Vocabulary 12.38 (2.68) 11.40 (2.94) 12.45 (2.65) 11.94 (2.77) .27  




Table 5. Descriptive Statistics for Demographics for SZ Clusters and HC group  
 
Note: Cluster 1 = Normal Functioning Cluster 
Cluster 2 = Impaired Transportation Cluster 
Cluster 3 = Impaired Finance Management Cluster 
Cluster 4 = Severely Impaired Cluster 
Cluster 5 = Moderately Impaired Cluster  
  
 SZ C1 
n = 23 
SZ C2 
n = 19 
SZ C3 
n = 12 
SZ C4 
n = 5 
SZ C5 
n = 12 
HC 
n = 50 
p 
Age (M, SD) 44.91 (12.27) 41.84 (13.66) 45.60 (11.10) 45.60 (4.10) 38.17 (13.13) 36.76 (14.18) .16 
Education (M, SD) 12.96 (2.06) 11.74 (1.63) 10.92 (1.78) 11.40 (1.34) 11.92 (2.39) 14.04 (2.07) < .001 
Marital Status (%)       .63 
Never Married 69.9 47.4 66.7 60.0 58.3 44.0  
In a relationship  4.3 15.8 16.7 0.0 16.7 18.0  
Married 8.7 15.8 8.3 20.0 0.0 14.0  
Divorced 13.0 0.0 0.0 20.0 25.0 14.0  
Separated 4.3 15.8 0.0 0.0 0.0 8.0  
Widowed 0.0 5.3 8.3 0.0 0.0 2.0  
Employment Status (%)       <.001 
Paid Employment 21.7 10.5 33.3 0.0 25.0 46.0  
Student 0.0 5.9 0.0 0.0 0.0 32.0  
Unemployed 78.3 84.2 66.7 100.0 75.0 22.0  
Medication Status       .11 
Mood Stabilizers 4.3 0.0 25.0 0.0 8.3 --  
Antipsychotics 82.6 89.5 91.7 80.0 91.7 --  
Anticonvulsants 30.4 31.6 25.0 80.0 33.3 --  




Table 5 (continued). Descriptive Statistics for Demographics for SZ Clusters and HC group  
 SZ C1 
n = 23 
SZ C2 
n = 19 
SZ C3 
n = 12 
SZ C4 
n = 5 
SZ C5 
n = 12 
HC 
n = 50 
p 
Female (%)  39.1 52.6 33.3 40.0 50.0 52.0 .80 
Ethnicity (%)       .32 
Caucasian  60.9 63.2 58.3 20.0 50.0 56.0  
African American 17.4 21.1 33.3 40.0 16.7 18.0  
Hispanic/Latino 13.0 0.0 8.3 20.0 25.0 8.0  
Asian American 4.3 0.0 0.0 0.0 0.0 14.0  
Biracial 4.3 10.5 0.0 20.0 0.0 4.0  
    Other 0.0 5.3 0.0 0.0 8.3 0.0  
Handedness (%)       .36 
Right  82.6 84.2 100.0 100.0 83.3 94.0  
Left 17.4 15.8 0.0 0.0 16.7 6.0  
 
Note: Cluster 1 = Normal Functioning Cluster 
Cluster 2 = Impaired Transportation Cluster 
Cluster 3 = Impaired Finance Management Cluster 
Cluster 4 = Severely Impaired Cluster 





Table 6. Descriptive Statistics and Post-Hoc Analyses for External Validity Variables for SZ Clusters and HC group 
Note: BPRS = Brief Psychiatric Rating Scale; SANS = Scale for the Assessment of Negative Symptoms (SANS); SAPS = Scale for 
the Assessment of Positive Symptoms (SAPS); GAF = Global Assessment of Functioning; HDRS = Hamilton Depression Rating 
Scale; YMRS = Young Mania Rating Scale; Cluster 1 = Normal Functioning Cluster; Cluster 2 = Impaired Transportation Cluster; 





n = 23 
SZ C2 
n = 19 
SZ C3 
n = 12 
SZ C4 
n = 5 
SZ C5 
n = 12 
HC 
n = 50 
p Tukey’s B 
BPRS          
Affective 
Flattening 
11.39 (3.96) 11.42 (3.36) 9.67 (3.11) 8.60 (2.19) 9.58 (2.61) 7.00 (2.56) <.001 HC < C1, C2 
Anergia 6.35 (2.79) 6.42 (3.42) 6.67 (3.23) 10.00 (3.67) 7.42 (3.78) 4.28 (.95) <.001 HC < C5;  
All < C4 
Disorganization 4.78 (2.28) 4.68 (1.45) 5.00 (1.95) 5.00 (1.87) 5.75 (2.67) 3.32 (.82) <.001 HC < C5 
Thought 
Disorder 
11.17 (4.93) 11.79 (4.60) 12.50 (5.07) 14.00 (4.00) 13.58 (5.45) 4.16 (.51) <.001 HC < C1-C5 
SAPS         
Delusions 6.48 (6.26) 6.68 (5.40) 5.67 (4.08) 6.00 (4.74) 12.25 
(11.51) 
.08 (.24) <.001 HC < C1-C5;  
C1-C4 < C5 
Hallucinations 6.35 (7.18) 5.05 (5.84) 7.42 (6.11) 11.60 (10.92) 9.58 (7.69) .00 (.00) <.001 HC < C1, C3-C5;  
C2 < C4 
Bizarre Behavior .74 (.81) .74 (1.19) 1.17 (1.80) 2.40 (2.61) 1.08 (2.19) .14 (.73) .001 HC, C1, C2 < C4 
Thought 
Disorder 
4.43 (3.37) 3.10 (4.28) 3.67 (4.01) 4.20 (3.50) 6.75 (4.05) .34 (1.91) <.001 HC < C1, C4, 
C5;  
C2 < C5 
SANS         
Affective 
Flattening 
5.26 (6.10) 3.63 (4.62) 6.08 (8.59) 12.20 (7.05) 9.92 (9.77) .72 (2.05) <.001 HC < C4, C5;  
C1-C3 < C4 
Alogia 1.43 (2.56) 1.37 (1.98) 1.08 (2.15) 4.00 (4.53) 2.33 (3.45) .28 (1.05) .001 HC, C1-C3 < C4 
Avolition 2.83 (2.69) 3.05 (2.93) 2.33 (2.84) 3.40 (2.97) 4.17 (3.66) .46 (1.09) <.001 HC < C4, C5 
Anhedonia 4.22 (4.97) 5.21 (4.10) 3.42 (4.17) 5.80 (2.77) 4.58 (3.60) .70 (1.71) <.001 HC < C2, C4, C5 
Attention 1.70 (1.96) 1.16 (1.42) 3.08 (1.78) 2.00 (2.00) 3.00 (1.81) .34 (.75) <.001 HC < C3-C5;  









n = 23 
SZ C2 
n = 19 
SZ C3 
n = 12 
SZ C4 
n = 5 
SZ C5 
n = 12 
HC 
n = 50 
p Tukey’s B 
GAF         
Functioning 46.61 (8.52) 48.05 
(11.90) 
46.42 (6.83) 41.60 (6.07) 44.25 
(6.43) 
81.98 (9.42) <.001 HC > C1-C5 
Symptomology 41.96 (9.26) 43.84 
(13.00) 
39.00 (7.36) 36.20 (5.22) 38.92 
(7.65) 
83.96 (8.60) <.001 HC > C1-C5 
HDRS 4.57 (5.06) 5.42 (5.99) 5.67 (4.21) 9.00 (5.52) 3.67 (3.03) 2.28 (3.04) .003 HC, C5 < C4 
YMRS 5.83 (6.23) 5.05 (5.71) 7.67 (7.95) 8.00 (5.10) 5.42 (5.70) .98 (2.19) <.001 HC < C3, C4 
Hospitalizations 2.43 (5.19) 3.00 (2.89) 4.58 (5.74) 7.00 (7.65) 2.33 (3.39) -- .27  
IQ         
Block Design 9.09 (2.56) 6.89 (2.20) 7.25 (1.91) 5.40 (1.14) 6.17 (2.12) 10.92 (2.78) <.001 HC > C2-C5;  
C1 > C4-C5 
Vocabulary 9.70 (2.98) 8.74 (3.11) 6.83 (2.37) 4.40 (1.14) 6.42 (2.50) 11.94 (2.77) <.001 HC > C2-C5;  
C1 > C4, C5 
C2 > C4 










HC > C2-C5;  
C1 > C4, C5; 
C2 > C4 
Note: BPRS = Brief Psychiatric Rating Scale; SANS = Scale for the Assessment of Negative Symptoms (SANS); SAPS = Scale for 
the Assessment of Positive Symptoms (SAPS); GAF = Global Assessment of Functioning; HDRS = Hamilton Depression Rating 
Scale; YMRS = Young Mania Rating Scale; Current IQ estimates were calculated using WAIS-III Vocabulary and Block Design 
subtest scores and regressed on the equation developed by Ringe and colleagues (2002); Cluster 1 = Normal Functioning Cluster; 
Cluster 2 = Impaired Transportation Cluster; Cluster 3 = Impaired Finance Management Cluster; Cluster 4 = Severely Impaired 

































Figure 1. Cluster Solutions for BD group (Frames A, B, and C). 
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Figure 2. Cluster Solutions for SZ group (Frames A, B, and C) 
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Paul, N. B., Emami, A. S., Hussey, J., Mayfield, J. W., & Allen, D. N. Executive functions 





the 36th annual National Academy of Neuropsychology Convention. Seattle, WA. 
October 21, 2016.  
 
Emami, A. S., Rozalski, V., & Holland, J. M. Grief related to loss of functioning and 
problematic drinking among older adults. Poster presented at the 96th annual Western 
Psychological Association Convention. Long Beach, CA. April 30, 2016. 
 
Emami, A. S., McCann, K., Phonsane, D., Lamb, V., Crews, B., & Pulvers, K. Acculturative 
stress and anxiety linked to pain among Hispanic women. Poster presented at the 96th 
annual Western Psychological Association Convention, Long Beach, CA. April 30, 2016.  
 
Ridenour, C., Hamill, S. Romero, D., Emami, A. S., Woodcock, A., & Pulvers, K. The role of 
hope in understanding the link between perceived stress and tobacco and marijuana use 
among adolescents. Poster presented at the 96th annual Western Psychological 
Association Convention, Long Beach, CA. April 28, 2016.  
 
Pulvers, K., Emami, A. S., Nollen, N. L., Romero, D. R., Strong, D. R., Benowitz, N. L., 
Ahluwalia, J. S. Tobacco consumption and harm exposure of cigarette smokers switching 
to electronic cigarettes. Poster presented at the Society for Research on Nicotine and 
Tobacco Meeting. Chicago, IL. March 4, 2016. 
 
Emami, A. S., Gonzales, M., Gary, M., Lamb, V., Ramirez, A., & Pulvers, K. The relationship 
between depression, anxiety, and marijuana use is moderated by  gender. Poster 
presented at the 95th Annual Western Psychological Association Convention. Las Vegas, 
NV. April 30, 2015 
 
Nilsen, S., Amba-Pascua, A., Emami, A. S., Kaphahn, T., & Pulvers, K. High levels of anxiety 
sensitivity and low self-esteem can predict negative eating attitudes. Poster presented at 
the 95th Annual Western Psychological Association Convention. Las Vegas, NV. April 
30, 2015 
 
Nilsen, S., Emami, A. S., Kessler, D., Gonzales, M., Kliebenstein, A., & Pulvers, K. Sexual 
compulsivity is associated with anxiety, depression, and Internet addiction. Poster 
presented at the 95th Annual Western Psychological Association Convention. Las Vegas, 
NV. April 30, 2015.  
 
Amba-Pascua, A., Nilsen, S., Emami, A. S., Kapphahn T., & Pulvers, K. Low distress tolerance 
can elevate the risk for developing eating disorders among college students. Poster 
presented at the 95th Annual Western Psychological Association Convention. Las Vegas, 
NV. April 30, 2015 
   
 Emami, A. S., Swanson, H., Kapphahn, T., Brady, G., & Pulvers, K. Pain catastrophizing 
mediates the relationship between emotions and unhealthy eating behavior among 
college students. Poster presented at the Annual Association for Psychological Science 






Basora, B., Roome, N., Amba-Pascua, A., Emami, A. S., Brady, G., & Pulvers, K. Poor emotion 
regulation is associated with Internet addiction. Poster presented at the Annual Western 
Psychological Association Convention. Portland, OR. April 26, 2014. 
 
Gonzales, M., Hackbardt, M., Emami, A. S., Brady, G., & Pulvers, K. Low distress tolerance 
and difficulties in emotional regulation are associated with sexual compulsivity. Poster 
presented at the Annual Western Psychological Association Convention. Portland, OR. 
April 26, 2014. 
 
Kapphahn, T., Emami, A. S., Swanson, H., Brady, G., & Pulvers, K. Poor emotion regulation is 
associated with alcohol use and drinking motives. Poster presented at the 94th Annual 
Western Psychological Association Convention. Portland, OR. April 25, 2014.  
 
Pulvers, K., Scheuermann, T. S., Basora, B., Emami, A. S., Luo, X., Khariwala, S. S., & 
Ahluwalia, J. S. Reasons for smoking among tri-ethnic daily and nondaily smokers. 
Poster presented at the Annual Society for Research on Nicotine and Tobacco Meeting. 
Seattle, WA. February 7, 2014. 
 
Gonzales, M., Hackbardt, M., Emami, A. S., Brady, G., & Pulvers, K. Low distress tolerance 
and difficulties with emotional regulation are associated with sexual compulsivity. Poster 
presented at the California State University San Marcos Student Poster Showcase. San 
Marcos, CA. November 21, 2013. 
  
Nicoll, D., Pirogovosky, E., Collazo, A. E., Goldstein, Tierney, S., J., Emami, A. S., Corey-
Bloom, J., & Gilbert, P. E. The effect of interference on visuospatial temporal order 
memory during the premanifest and manifest stages of Huntington’s disease. Poster 
presented at the Annual Society for Neuroscience. San Diego, CA. November 12, 2013. 
 
Emami, A. S., Tierney, S. M., Collazo, A. E., Pirogovsky, E., Nicoll, D., Goldstein, J., Corey-
Bloom, J., Gilbert, P. E. Temporal order memory deficits in Huntington’s disease. Poster 
presented at the University of California Los Angeles Psychology Undergraduate 
Research Conference. Los Angeles, CA. May 10, 2013. 
 
Emami, A. S., Collazo, A. E., Pirogovsky, E., Nicoll, D., Goldstein, J., Corey-Bloom, J., Gilbert, 
P. E. Temporal order memory deficits in Huntington’s disease. Oral presentation given at 
the San Diego State University Student Research Symposium. San Diego, CA. March 9, 
2013.  
 
Nicoll, D., Collazo, A. E., Pirogovsky, E., Goldstein, J., Emami, A. S., Corey-Bloom, J., Gilbert, 
P. E. Temporal order memory deficits in Huntington’s disease. Poster presented at the 
Annual Society for Neuroscience. New Orleans, LA. October 17, 2012.  
 
INVITED TALKS, LECTURES, AND WORKSHOPS 
Work, leisure, and retirement (Lecture). November 12, 2015. University of Nevada, Las Vegas 






How to format an APA paper (Workshop). February 20, 2015. CSUSM. Invited by: Heike 
Mahler, PhD  
 
Psychology Academic Resource Lab (PARL) Graduate school workshop series (Workshops). 
October 14, 2014 and October 28, 2014. CSUSM. Invited by: Heike Mahler, PhD 
 
Learn more about CSUSM’s Psychology department (Talk). October 12, 2013. Grossmont 
College. Invited by: Sandra Sanchez, M.A. 
 
An alumni’s experience with psychology (Talks). May 21, 2013 and May 19, 2014. Steele 
Canyon High School. Invited by: Joan Lange-Smith.  
 
How to present your research (Talk). May 20, 2013. Grossmont College. Invited by: Amy 
Ramos, PhD.  
 
What to expect when you transfer: A PsyMORE Presentation (Talk). May 12, 2013.  Mesa 
College. Invited by: Jaye Van Kirk, M.A. and City College’s Psi Beta chapter.  
 
PROFESSIONAL SERVICE 
Abstract Reviewer for Student Research Awards (04/2019)             
Association for Psychological Science Annual Convention 
 
Student Event Volunteer (05/2018)           
Association for Psychological Science Annual Convention in San Francisco, CA 
 
Mentor for the Outreach Undergraduate Mentoring Program (OUMP)     08/2015 - 05/2019 
University of Nevada, Las Vegas 
• Program’s goal is to provide mentoring to students who are traditionally underrepresented in 
the field of psychology with information regarding class work, research, and other areas 
required for eligibility and entrance into graduate programs.  
 
Invited Reviewer                         2015  
Journals: Death Studies and Eating Behaviors 
 
Mental Health Awareness Day Volunteer                            05/2013 and 05/2014 
Grossmont College 
• An annual event, which aims to reduce stigma associated with mental health disorders. Event 
includes discussions among mental health professionals and individuals discussing their 
struggles with mental health. I helped to recruit event volunteers and oversaw operations on 
the day of the event.  
 
Event Volunteer                        07/2013 – 07/2014 
Special Olympics Organization, San Diego Region 
 
Event Volunteer                  05/2013 
Expand your Horizons of San Diego 





Mentor for the Psychology Mentoring Outreach Program (PsyMORE)     08/2012 – 05/2013 
San Diego State University 
 
COMMITTEE MEMBERSHIP 
The PRACTICE Advisory Board Student Representative       05/2018 – 05/2019 
University of Nevada, Las Vegas 
 
Clinical Student Committee Representative for 4th year cohort       05/2018 – 05/2019 
University of Nevada, Las Vegas 
 
Graduate Studies Council Representative          08/2013 – 05/2014 
California State University San Marcos 
 
AWARDS AND HONORS 
UNLV Summer Doctoral Research Fellowship                      2018 
UNLV Patricia Sastaunik Scholarship                      2018 
Association for Psychological Science Travel Grant Award         2018         
UNLV GPSA Travel Award             Fall 2017 and Fall 2018   
CSUSM Graduate Dean’s Award Nominee for Psychology Department       2016 
First place in American Psychological Association Division 52/International       2016 
Psychology Student Poster Competition 
CSUSM Graduate Studies Conference Travel Award       Spring 2015 
CSUSM Student Travel and Conference Award               Spring 2014 - Fall 2015 
SDSU Summa Cum Laude Graduate with Distinction in Psychology        2013 
SDSU Dean’s List               2013 
Most Dedicated to Research, SDSU Psychology Department Awards       2013 
Barnes and Noble Scholarship Recipient                      2011 - 2012 
American Association of University Women Scholarship         2011 
Grossmont-Cuyamaca Community College District Dean’s List         2011 
Grossmont-Cuyamaca Community College District President’s List                 2009 - 2010 
 
MEMBERSHIPS IN PROFESSIONAL SOCIETIES 
National Academy of Neuropsychology Student Member                          2016 - Present 
Western Psychological Association Student Affiliate                2014 - Present 
Association for Psychological Science Student Affiliate                2014 - Present 
Phi Kappa Phi, top 10 percent of undergraduate senior class at SDSU        2013     
Psi Chi (International Honor Society in Psychology) Member              2011 - Present 
